CN113194908B - Kit for caring skin - Google Patents
Kit for caring skin Download PDFInfo
- Publication number
- CN113194908B CN113194908B CN201880100560.0A CN201880100560A CN113194908B CN 113194908 B CN113194908 B CN 113194908B CN 201880100560 A CN201880100560 A CN 201880100560A CN 113194908 B CN113194908 B CN 113194908B
- Authority
- CN
- China
- Prior art keywords
- water
- composition
- soluble
- multivalent metal
- insoluble
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 claims abstract description 202
- 229920000642 polymer Polymers 0.000 claims abstract description 65
- 150000003839 salts Chemical class 0.000 claims abstract description 62
- 239000003349 gelling agent Substances 0.000 claims abstract description 57
- 229910021645 metal ion Inorganic materials 0.000 claims abstract description 51
- 239000000463 material Substances 0.000 claims abstract description 43
- 229910052751 metal Inorganic materials 0.000 claims abstract description 42
- 239000002184 metal Substances 0.000 claims abstract description 42
- 239000002738 chelating agent Substances 0.000 claims abstract description 34
- 108010076876 Keratins Proteins 0.000 claims abstract description 17
- 102000011782 Keratins Human genes 0.000 claims abstract description 17
- 239000008346 aqueous phase Substances 0.000 claims abstract description 16
- -1 alkali metal alginic acid compounds Chemical class 0.000 claims description 69
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 63
- 235000010443 alginic acid Nutrition 0.000 claims description 59
- 229920000615 alginic acid Polymers 0.000 claims description 59
- 239000000835 fiber Substances 0.000 claims description 59
- 239000000758 substrate Substances 0.000 claims description 52
- 229920002678 cellulose Polymers 0.000 claims description 42
- 229910052783 alkali metal Inorganic materials 0.000 claims description 40
- 235000010980 cellulose Nutrition 0.000 claims description 34
- 239000001913 cellulose Substances 0.000 claims description 32
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 28
- 229940072056 alginate Drugs 0.000 claims description 27
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 25
- 239000002253 acid Substances 0.000 claims description 22
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 20
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 19
- 239000000783 alginic acid Substances 0.000 claims description 18
- 229960001126 alginic acid Drugs 0.000 claims description 18
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 17
- 150000001340 alkali metals Chemical class 0.000 claims description 15
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 14
- 150000004781 alginic acids Chemical class 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 12
- 239000004745 nonwoven fabric Substances 0.000 claims description 12
- 239000013543 active substance Substances 0.000 claims description 11
- 239000004744 fabric Substances 0.000 claims description 11
- 229910052700 potassium Inorganic materials 0.000 claims description 11
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 10
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 10
- 235000010413 sodium alginate Nutrition 0.000 claims description 10
- 239000000661 sodium alginate Substances 0.000 claims description 10
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 9
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 9
- 239000011575 calcium Substances 0.000 claims description 9
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 9
- 239000011591 potassium Substances 0.000 claims description 9
- 229940005550 sodium alginate Drugs 0.000 claims description 9
- 239000001509 sodium citrate Substances 0.000 claims description 9
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical class [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 8
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 8
- 229920000742 Cotton Polymers 0.000 claims description 8
- 229910052791 calcium Inorganic materials 0.000 claims description 8
- 235000010410 calcium alginate Nutrition 0.000 claims description 8
- 239000000648 calcium alginate Substances 0.000 claims description 8
- 229960002681 calcium alginate Drugs 0.000 claims description 8
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 8
- 229910052744 lithium Inorganic materials 0.000 claims description 8
- 159000000007 calcium salts Chemical class 0.000 claims description 7
- 150000001768 cations Chemical class 0.000 claims description 7
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 7
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical class [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 6
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 6
- 229920000297 Rayon Polymers 0.000 claims description 6
- 239000010949 copper Chemical class 0.000 claims description 6
- 229910052802 copper Inorganic materials 0.000 claims description 6
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical group O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 6
- 229920000433 Lyocell Polymers 0.000 claims description 5
- 238000013329 compounding Methods 0.000 claims description 5
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 5
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 5
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 5
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 5
- 235000010408 potassium alginate Nutrition 0.000 claims description 5
- 239000000737 potassium alginate Substances 0.000 claims description 5
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 claims description 5
- VKZRWSNIWNFCIQ-WDSKDSINSA-N (2s)-2-[2-[[(1s)-1,2-dicarboxyethyl]amino]ethylamino]butanedioic acid Chemical compound OC(=O)C[C@@H](C(O)=O)NCCN[C@H](C(O)=O)CC(O)=O VKZRWSNIWNFCIQ-WDSKDSINSA-N 0.000 claims description 4
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical class [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 4
- 229920013819 hydroxyethyl ethylcellulose Polymers 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- 235000005985 organic acids Nutrition 0.000 claims description 4
- 235000002949 phytic acid Nutrition 0.000 claims description 4
- 229910052712 strontium Inorganic materials 0.000 claims description 4
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical class [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 claims description 4
- 239000011701 zinc Chemical class 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- RPZANUYHRMRTTE-UHFFFAOYSA-N 2,3,4-trimethoxy-6-(methoxymethyl)-5-[3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxyoxane;1-[[3,4,5-tris(2-hydroxybutoxy)-6-[4,5,6-tris(2-hydroxybutoxy)-2-(2-hydroxybutoxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]butan-2-ol Chemical compound COC1C(OC)C(OC)C(COC)OC1OC1C(OC)C(OC)C(OC)OC1COC.CCC(O)COC1C(OCC(O)CC)C(OCC(O)CC)C(COCC(O)CC)OC1OC1C(OCC(O)CC)C(OCC(O)CC)C(OCC(O)CC)OC1COCC(O)CC RPZANUYHRMRTTE-UHFFFAOYSA-N 0.000 claims description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 3
- FENRSEGZMITUEF-ATTCVCFYSA-E [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] FENRSEGZMITUEF-ATTCVCFYSA-E 0.000 claims description 3
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical class [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 3
- 229910052698 phosphorus Inorganic materials 0.000 claims description 3
- 239000011574 phosphorus Substances 0.000 claims description 3
- 229940083982 sodium phytate Drugs 0.000 claims description 3
- UZVUJVFQFNHRSY-OUTKXMMCSA-J tetrasodium;(2s)-2-[bis(carboxylatomethyl)amino]pentanedioate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CC[C@@H](C([O-])=O)N(CC([O-])=O)CC([O-])=O UZVUJVFQFNHRSY-OUTKXMMCSA-J 0.000 claims description 3
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 claims description 2
- DRAJWRKLRBNJRQ-UHFFFAOYSA-N Hydroxycarbamic acid Chemical compound ONC(O)=O DRAJWRKLRBNJRQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000004627 regenerated cellulose Substances 0.000 claims description 2
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 claims description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 9
- 201000009859 Osteochondrosis Diseases 0.000 abstract description 5
- 206010060932 Postoperative adhesion Diseases 0.000 abstract description 5
- 206010072170 Skin wound Diseases 0.000 abstract description 5
- 238000011049 filling Methods 0.000 abstract description 5
- 229920001282 polysaccharide Polymers 0.000 description 46
- 239000005017 polysaccharide Substances 0.000 description 46
- 150000004804 polysaccharides Chemical class 0.000 description 41
- 210000003491 skin Anatomy 0.000 description 35
- 229920002674 hyaluronan Polymers 0.000 description 29
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 28
- 229960003160 hyaluronic acid Drugs 0.000 description 28
- 239000000499 gel Substances 0.000 description 27
- 239000000047 product Substances 0.000 description 25
- 238000000034 method Methods 0.000 description 21
- 125000002091 cationic group Chemical group 0.000 description 19
- 239000003795 chemical substances by application Substances 0.000 description 19
- 244000303965 Cyamopsis psoralioides Species 0.000 description 18
- 229920002125 Sokalan® Polymers 0.000 description 16
- 238000011156 evaluation Methods 0.000 description 16
- 238000009472 formulation Methods 0.000 description 16
- 229920000926 Galactomannan Polymers 0.000 description 14
- 229920002907 Guar gum Polymers 0.000 description 14
- 125000000217 alkyl group Chemical group 0.000 description 14
- 239000000665 guar gum Substances 0.000 description 14
- 235000010417 guar gum Nutrition 0.000 description 14
- 229960002154 guar gum Drugs 0.000 description 14
- 239000011734 sodium Substances 0.000 description 14
- 125000004432 carbon atom Chemical group C* 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 13
- 230000001815 facial effect Effects 0.000 description 13
- 229920001277 pectin Polymers 0.000 description 13
- 235000010987 pectin Nutrition 0.000 description 13
- 239000001814 pectin Substances 0.000 description 13
- 229910052708 sodium Inorganic materials 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 239000000839 emulsion Substances 0.000 description 12
- 229920000591 gum Polymers 0.000 description 12
- 239000007788 liquid Substances 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 11
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 11
- 235000010420 locust bean gum Nutrition 0.000 description 11
- 229920001202 Inulin Polymers 0.000 description 10
- 229920000161 Locust bean gum Polymers 0.000 description 10
- 125000000129 anionic group Chemical group 0.000 description 10
- 239000001768 carboxy methyl cellulose Substances 0.000 description 10
- 229920001525 carrageenan Polymers 0.000 description 10
- 229920001577 copolymer Polymers 0.000 description 10
- 229940014041 hyaluronate Drugs 0.000 description 10
- 229940029339 inulin Drugs 0.000 description 10
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 10
- 239000000711 locust bean gum Substances 0.000 description 10
- 235000015424 sodium Nutrition 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 229920001817 Agar Polymers 0.000 description 9
- 229920002307 Dextran Polymers 0.000 description 9
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 9
- 229960002086 dextran Drugs 0.000 description 9
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 9
- 229920000728 polyester Polymers 0.000 description 9
- 229920001285 xanthan gum Polymers 0.000 description 9
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 8
- 241000195493 Cryptophyta Species 0.000 description 8
- 229920001218 Pullulan Polymers 0.000 description 8
- 239000004373 Pullulan Substances 0.000 description 8
- 235000010419 agar Nutrition 0.000 description 8
- 239000008272 agar Substances 0.000 description 8
- 229940023476 agar Drugs 0.000 description 8
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical group OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 8
- 235000010418 carrageenan Nutrition 0.000 description 8
- 230000032050 esterification Effects 0.000 description 8
- 238000005886 esterification reaction Methods 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 229920000151 polyglycol Polymers 0.000 description 8
- 239000010695 polyglycol Substances 0.000 description 8
- 229960003975 potassium Drugs 0.000 description 8
- 235000019423 pullulan Nutrition 0.000 description 8
- 235000010493 xanthan gum Nutrition 0.000 description 8
- 239000000230 xanthan gum Substances 0.000 description 8
- 229940082509 xanthan gum Drugs 0.000 description 8
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 7
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 7
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 7
- 229920002581 Glucomannan Polymers 0.000 description 7
- 150000007513 acids Chemical class 0.000 description 7
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 7
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 7
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 7
- 239000000679 carrageenan Substances 0.000 description 7
- 229940113118 carrageenan Drugs 0.000 description 7
- 229920003086 cellulose ether Polymers 0.000 description 7
- AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 description 7
- 229920000609 methyl cellulose Polymers 0.000 description 7
- 235000010981 methylcellulose Nutrition 0.000 description 7
- 239000001923 methylcellulose Substances 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 230000007704 transition Effects 0.000 description 7
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 7
- ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 description 6
- FEBUJFMRSBAMES-UHFFFAOYSA-N 2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl phosphinite Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(OC2C(C(OP)C(O)C(CO)O2)O)C(O)C(OC2C(C(CO)OC(P)C2O)O)O1 FEBUJFMRSBAMES-UHFFFAOYSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 229920002670 Fructan Polymers 0.000 description 6
- 229920002148 Gellan gum Polymers 0.000 description 6
- 229920002752 Konjac Polymers 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- 241000282372 Panthera onca Species 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 229920002305 Schizophyllan Polymers 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 229930182830 galactose Natural products 0.000 description 6
- 229960003082 galactose Drugs 0.000 description 6
- 230000036571 hydration Effects 0.000 description 6
- 238000006703 hydration reaction Methods 0.000 description 6
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 5
- 229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 description 5
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 5
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 5
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 5
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 5
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 5
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical group CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 5
- 241000206572 Rhodophyta Species 0.000 description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- 235000010492 gellan gum Nutrition 0.000 description 5
- 239000000216 gellan gum Substances 0.000 description 5
- 235000011083 sodium citrates Nutrition 0.000 description 5
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 4
- VFKZECOCJCGZQK-UHFFFAOYSA-M 3-hydroxypropyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CCCO VFKZECOCJCGZQK-UHFFFAOYSA-M 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 229920002683 Glycosaminoglycan Polymers 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 241000199919 Phaeophyceae Species 0.000 description 4
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000000061 acid fraction Substances 0.000 description 4
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 4
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 4
- 229920013820 alkyl cellulose Polymers 0.000 description 4
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 4
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 235000011132 calcium sulphate Nutrition 0.000 description 4
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 150000002170 ethers Chemical class 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 229940097043 glucuronic acid Drugs 0.000 description 4
- 229960005150 glycerol Drugs 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 235000010485 konjac Nutrition 0.000 description 4
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 230000019635 sulfation Effects 0.000 description 4
- 238000005670 sulfation reaction Methods 0.000 description 4
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- IRLPACMLTUPBCL-KQYNXXCUSA-N 5'-adenylyl sulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](O)[C@H]1O IRLPACMLTUPBCL-KQYNXXCUSA-N 0.000 description 3
- 244000215068 Acacia senegal Species 0.000 description 3
- 244000247812 Amorphophallus rivieri Species 0.000 description 3
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 3
- 241000512259 Ascophyllum nodosum Species 0.000 description 3
- 241001474374 Blennius Species 0.000 description 3
- 235000017399 Caesalpinia tinctoria Nutrition 0.000 description 3
- 229920002101 Chitin Polymers 0.000 description 3
- 229920001661 Chitosan Polymers 0.000 description 3
- 125000002353 D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
- 239000001856 Ethyl cellulose Substances 0.000 description 3
- 229920001503 Glucan Polymers 0.000 description 3
- 229920000084 Gum arabic Polymers 0.000 description 3
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000388430 Tara Species 0.000 description 3
- 229920001615 Tragacanth Polymers 0.000 description 3
- 235000010489 acacia gum Nutrition 0.000 description 3
- 239000000205 acacia gum Substances 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 125000002877 alkyl aryl group Chemical group 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 229920000617 arabinoxylan Polymers 0.000 description 3
- 125000003710 aryl alkyl group Chemical group 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 229960000633 dextran sulfate Drugs 0.000 description 3
- 150000002016 disaccharides Chemical group 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 3
- 229940046240 glucomannan Drugs 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 3
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000000252 konjac Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 239000011859 microparticle Substances 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229960004838 phosphoric acid Drugs 0.000 description 3
- 230000026731 phosphorylation Effects 0.000 description 3
- 238000006366 phosphorylation reaction Methods 0.000 description 3
- 229920002401 polyacrylamide Polymers 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 229940068968 polysorbate 80 Drugs 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 3
- 229940038773 trisodium citrate Drugs 0.000 description 3
- 235000019263 trisodium citrate Nutrition 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 229920001221 xylan Polymers 0.000 description 3
- 150000004823 xylans Chemical class 0.000 description 3
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 3
- VCVKIIDXVWEWSZ-YFKPBYRVSA-N (2s)-2-[bis(carboxymethyl)amino]pentanedioic acid Chemical compound OC(=O)CC[C@@H](C(O)=O)N(CC(O)=O)CC(O)=O VCVKIIDXVWEWSZ-YFKPBYRVSA-N 0.000 description 2
- AEMOLEFTQBMNLQ-SYJWYVCOSA-N (2s,3s,4s,5s,6r)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-SYJWYVCOSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 2
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 description 2
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 description 2
- GHPVDCPCKSNJDR-UHFFFAOYSA-N 2-hydroxydecanoic acid Chemical compound CCCCCCCCC(O)C(O)=O GHPVDCPCKSNJDR-UHFFFAOYSA-N 0.000 description 2
- YDZIJQXINJLRLL-UHFFFAOYSA-N 2-hydroxydodecanoic acid Chemical compound CCCCCCCCCCC(O)C(O)=O YDZIJQXINJLRLL-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- AACHVWXCVWWMSI-UHFFFAOYSA-N 3-hydroxypropyl(trimethyl)azanium Chemical compound C[N+](C)(C)CCCO AACHVWXCVWWMSI-UHFFFAOYSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- 229920003043 Cellulose fiber Polymers 0.000 description 2
- 240000008886 Ceratonia siliqua Species 0.000 description 2
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- 244000298479 Cichorium intybus Species 0.000 description 2
- 235000007542 Cichorium intybus Nutrition 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 235000017367 Guainella Nutrition 0.000 description 2
- 240000008892 Helianthus tuberosus Species 0.000 description 2
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 2
- 229920000869 Homopolysaccharide Polymers 0.000 description 2
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 2
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 2
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 2
- 240000007472 Leucaena leucocephala Species 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 229920000057 Mannan Polymers 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 2
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 244000082204 Phyllostachys viridis Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- AEMOLEFTQBMNLQ-ORELYVPDSA-N alpha-L-glucopyranuronic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O AEMOLEFTQBMNLQ-ORELYVPDSA-N 0.000 description 2
- 230000009435 amidation Effects 0.000 description 2
- 238000007112 amidation reaction Methods 0.000 description 2
- 238000005576 amination reaction Methods 0.000 description 2
- 229940035674 anesthetics Drugs 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- 150000004783 arabinoxylans Chemical class 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 229940067599 ascorbyl glucoside Drugs 0.000 description 2
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 150000001277 beta hydroxy acids Chemical class 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 125000002843 carboxylic acid group Chemical group 0.000 description 2
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 229960005188 collagen Drugs 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000007854 depigmenting agent Substances 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000006266 etherification reaction Methods 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000451 gelidium spp. gum Substances 0.000 description 2
- 239000003193 general anesthetic agent Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 2
- 230000000887 hydrating effect Effects 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940031674 laureth-7 Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- LUEWUZLMQUOBSB-GFVSVBBRSA-N mannan Chemical class O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-GFVSVBBRSA-N 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 229950006780 n-acetylglucosamine Drugs 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229940068041 phytic acid Drugs 0.000 description 2
- 239000000467 phytic acid Substances 0.000 description 2
- 229920005646 polycarboxylate Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229940107700 pyruvic acid Drugs 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- UBXAKNTVXQMEAG-UHFFFAOYSA-L strontium sulfate Chemical compound [Sr+2].[O-]S([O-])(=O)=O UBXAKNTVXQMEAG-UHFFFAOYSA-L 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 239000012209 synthetic fiber Substances 0.000 description 2
- 235000010491 tara gum Nutrition 0.000 description 2
- 239000000213 tara gum Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 125000005208 trialkylammonium group Chemical group 0.000 description 2
- PUVAFTRIIUSGLK-UHFFFAOYSA-M trimethyl(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1CO1 PUVAFTRIIUSGLK-UHFFFAOYSA-M 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N urethane group Chemical group NC(=O)OCC JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 239000002759 woven fabric Substances 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- WZYRMLAWNVOIEX-MOJAZDJTSA-N (2s)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyacetaldehyde Chemical group O=C[C@@H](O)[C@@H]1OC[C@H](O)[C@H]1O WZYRMLAWNVOIEX-MOJAZDJTSA-N 0.000 description 1
- FYGDTMLNYKFZSV-WFYNLLPOSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,3s,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-WFYNLLPOSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- FZWBNHMXJMCXLU-UHFFFAOYSA-N 2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OCC(O)C(O)C(O)C(O)C=O)O1 FZWBNHMXJMCXLU-UHFFFAOYSA-N 0.000 description 1
- LCZVSXRMYJUNFX-UHFFFAOYSA-N 2-[2-(2-hydroxypropoxy)propoxy]propan-1-ol Chemical compound CC(O)COC(C)COC(C)CO LCZVSXRMYJUNFX-UHFFFAOYSA-N 0.000 description 1
- IXIGWKNBFPKCCD-UHFFFAOYSA-N 2-hydroxy-5-octanoylbenzoic acid Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(O)=O)=C1 IXIGWKNBFPKCCD-UHFFFAOYSA-N 0.000 description 1
- AFENDNXGAFYKQO-UHFFFAOYSA-N 2-hydroxybutyric acid Chemical compound CCC(O)C(O)=O AFENDNXGAFYKQO-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- BWLBGMIXKSTLSX-UHFFFAOYSA-N 2-hydroxyisobutyric acid Chemical compound CC(C)(O)C(O)=O BWLBGMIXKSTLSX-UHFFFAOYSA-N 0.000 description 1
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241000223602 Alternaria alternata Species 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 229920000189 Arabinogalactan Polymers 0.000 description 1
- 241000209524 Araceae Species 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 125000006577 C1-C6 hydroxyalkyl group Chemical group 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 229920008347 Cellulose acetate propionate Polymers 0.000 description 1
- 241000561734 Celosia cristata Species 0.000 description 1
- 241000024244 Chelis Species 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- QXKAIJAYHKCRRA-JJYYJPOSSA-N D-arabinonic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(O)=O QXKAIJAYHKCRRA-JJYYJPOSSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- 125000003436 D-mannopyranosyl group Chemical group [H]OC([H])([H])[C@@]1([H])OC([H])(*)[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H] 0.000 description 1
- 125000000214 D-xylosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)CO1)* 0.000 description 1
- 244000115658 Dahlia pinnata Species 0.000 description 1
- 235000012040 Dahlia pinnata Nutrition 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229920000896 Ethulose Polymers 0.000 description 1
- 239000001859 Ethyl hydroxyethyl cellulose Substances 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241000195480 Fucus Species 0.000 description 1
- 241000227647 Fucus vesiculosus Species 0.000 description 1
- 241001134786 Furcellaria Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 241001147462 Gigartinaceae Species 0.000 description 1
- 229920001706 Glucuronoxylan Polymers 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 241000866892 Hispo Species 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 238000007696 Kjeldahl method Methods 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- NGEWQZIDQIYUNV-UHFFFAOYSA-N L-valinic acid Natural products CC(C)C(O)C(O)=O NGEWQZIDQIYUNV-UHFFFAOYSA-N 0.000 description 1
- 241001512709 Lessonia <stramenopiles> Species 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102220549062 Low molecular weight phosphotyrosine protein phosphatase_C13S_mutation Human genes 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 229920003091 Methocel™ Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 101800000789 Protease-polymerase p70 Proteins 0.000 description 1
- 101800000786 Protease-polymerase p76 Proteins 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UHFFFAOYSA-N Rohrzucker Natural products OCC1OC(CO)(OC2OC(CO)C(O)C(O)C2O)C(O)C1O CZMRCDWAGMRECN-UHFFFAOYSA-N 0.000 description 1
- 241000983742 Saccharina Species 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 240000001058 Sterculia urens Species 0.000 description 1
- 235000015125 Sterculia urens Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241000589636 Xanthomonas campestris Species 0.000 description 1
- 229920002000 Xyloglucan Polymers 0.000 description 1
- SFRPDSKECHTFQA-ONOWFSFQSA-N [(2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] propanoate Chemical compound CCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SFRPDSKECHTFQA-ONOWFSFQSA-N 0.000 description 1
- ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2r,3s,4r,5r,6s)-6-[[(1r,3s,4r,5r,8s)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1r,3r,4r,5r,8s)-8-[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- UGXQOOQUZRUVSS-ZZXKWVIFSA-N [5-[3,5-dihydroxy-2-(1,3,4-trihydroxy-5-oxopentan-2-yl)oxyoxan-4-yl]oxy-3,4-dihydroxyoxolan-2-yl]methyl (e)-3-(4-hydroxyphenyl)prop-2-enoate Chemical compound OC1C(OC(CO)C(O)C(O)C=O)OCC(O)C1OC1C(O)C(O)C(COC(=O)\C=C\C=2C=CC(O)=CC=2)O1 UGXQOOQUZRUVSS-ZZXKWVIFSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- UGZICOVULPINFH-UHFFFAOYSA-N acetic acid;butanoic acid Chemical compound CC(O)=O.CCCC(O)=O UGZICOVULPINFH-UHFFFAOYSA-N 0.000 description 1
- AVMNFQHJOOYCAP-UHFFFAOYSA-N acetic acid;propanoic acid Chemical compound CC(O)=O.CCC(O)=O AVMNFQHJOOYCAP-UHFFFAOYSA-N 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical compound CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 229920001284 acidic polysaccharide Polymers 0.000 description 1
- 150000004805 acidic polysaccharides Chemical class 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000010564 aerobic fermentation Methods 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000014104 aloe vera supplement Nutrition 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 125000003550 alpha-D-galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- WQZGKKKJIJFFOK-PQMKYFCFSA-N alpha-D-mannose Chemical compound OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-PQMKYFCFSA-N 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-N alpha-L-IdopA-(1->3)-beta-D-GalpNAc4S Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS(O)(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C(O)=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-N 0.000 description 1
- HMFHBZSHGGEWLO-QMKXCQHVSA-N alpha-L-arabinofuranose Chemical group OC[C@@H]1O[C@@H](O)[C@H](O)[C@H]1O HMFHBZSHGGEWLO-QMKXCQHVSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- LCWAOCHOPBSGMU-UHFFFAOYSA-J aluminum;magnesium;sodium;hydrogen carbonate;oxygen(2-);silicon;trihydroxide Chemical compound [OH-].[OH-].[OH-].[O-2].[Na+].[Mg+2].[Al+3].[Si].OC([O-])=O LCWAOCHOPBSGMU-UHFFFAOYSA-J 0.000 description 1
- 235000019824 amidated pectin Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940093740 amino acid and derivative Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 229920006321 anionic cellulose Polymers 0.000 description 1
- 229920001586 anionic polysaccharide Polymers 0.000 description 1
- 150000004836 anionic polysaccharides Chemical class 0.000 description 1
- 239000000420 anogeissus latifolia wall. gum Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000000058 anti acne agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000002682 anti-psoriatic effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 230000000656 anti-yeast Effects 0.000 description 1
- 229940124340 antiacne agent Drugs 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 229940125683 antiemetic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 235000019312 arabinogalactan Nutrition 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229940071097 ascorbyl phosphate Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 229960002255 azelaic acid Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- AEMOLEFTQBMNLQ-QIUUJYRFSA-N beta-D-glucuronic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-QIUUJYRFSA-N 0.000 description 1
- WQZGKKKJIJFFOK-RWOPYEJCSA-N beta-D-mannose Chemical group OC[C@H]1O[C@@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-RWOPYEJCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000001175 calcium sulphate Substances 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 125000004181 carboxyalkyl group Chemical group 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 150000001773 cellobioses Chemical class 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 210000001520 comb Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 229940119744 dextran 40 Drugs 0.000 description 1
- 229940119743 dextran 70 Drugs 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 239000002526 disodium citrate Substances 0.000 description 1
- 235000019262 disodium citrate Nutrition 0.000 description 1
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 235000019326 ethyl hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010944 ethyl methyl cellulose Nutrition 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 235000019314 gum ghatti Nutrition 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229940099552 hyaluronan Drugs 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 229920013818 hydroxypropyl guar gum Polymers 0.000 description 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 235000019823 konjac gum Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940099563 lactobionic acid Drugs 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical group COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 229920003087 methylethyl cellulose Polymers 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- HWPKGOGLCKPRLZ-UHFFFAOYSA-M monosodium citrate Chemical compound [Na+].OC(=O)CC(O)(C([O-])=O)CC(O)=O HWPKGOGLCKPRLZ-UHFFFAOYSA-M 0.000 description 1
- 239000002524 monosodium citrate Substances 0.000 description 1
- 235000018342 monosodium citrate Nutrition 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WZZVUHWLNMNWLW-UHFFFAOYSA-N n-[5-[3-acetamido-5-[3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound OC1C(NC(=O)C)C(O)OC(CO)C1OC1C(NC(C)=O)C(O)C(OC2C(C(O)C(O)C(CO)O2)NC(C)=O)C(CO)O1 WZZVUHWLNMNWLW-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229950001046 piroctone Drugs 0.000 description 1
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 1
- 239000004854 plant resin Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920000157 polyfructose Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001289 polyvinyl ether Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- KYKNRZGSIGMXFH-ZVGUSBNCSA-M potassium bitartrate Chemical compound [K+].OC(=O)[C@H](O)[C@@H](O)C([O-])=O KYKNRZGSIGMXFH-ZVGUSBNCSA-M 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000001472 potassium tartrate Substances 0.000 description 1
- 229940111695 potassium tartrate Drugs 0.000 description 1
- 235000011005 potassium tartrates Nutrition 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- 150000004717 pyruvic acids Chemical class 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 229960002167 sodium tartrate Drugs 0.000 description 1
- 235000011004 sodium tartrates Nutrition 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 150000004043 trisaccharides Chemical group 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 229960003487 xylose Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
- A61K2800/882—Mixing prior to application
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
A kit, comprising: (1) A first composition comprising at least one water-insoluble multivalent metal salt and at least one water-soluble polyhydroxy polymer, and (2) a second composition comprising at least one aqueous phase, and a) optionally, at least one water-soluble multivalent metal ion chelating agent, and b) at least one water-soluble gelling agent that forms a gel with multivalent metal ions. The kit can be used for caring keratin materials, in particular skin, for managing skin wounds, for preventing post-operative adhesion formation or for filling or repairing osteochondral defects.
Description
Technical Field
The present invention relates to an alginic system, in particular to an alginic suit for caring skin. The invention also relates to the use thereof, in particular as a mask for caring for keratin materials, in particular the skin.
Background
The ultimate goal in the cosmetic field has always been to provide consumers with efficient products with skin benefits such as hydration, moisturization, whitening, cleansing, etc.
Among all compositions for caring for keratin materials, in particular the skin, masks are known to have a high osmotic efficacy for keratin materials. Therefore, two-digit market growth of facial mask cosmetics is seen in China.
There are generally four types of masks, namely, cream-type, peel-off type, gel-type, and wet wipe-type masks. Among them, the cream type and the peel-off type facial films are mainly used for cleansing keratin materials, and the gel type and the wet towel type facial films are more commonly used for skin care. It is known that gel type masks have good adhesion to the skin and can provide good freshness, but may not sufficiently deliver moisturizing or hydrating effects to the skin, whereas wet tissue type masks are good at delivering moisturizing and hydrating effects, but can be withdrawn if applied for a long period of time. Furthermore, the adhesion to the skin may not be as good as the gel profile.
Meanwhile, for a mask, particularly a facial tissue type mask, it is desirable that the mask applied to the face is soft to bring about better touch feeling and better skin fit.
Based on the foregoing, there is a need for a new mask that combines two or more of the advantages exhibited by known mask types, but that does not have one or more of the problems associated therewith.
Object of the Invention
Thus, in one aspect, it is desirable to provide a facial mask that is capable of undergoing a texture transition, such as from a tissue to a gel, to provide a pleasant consumer experience.
In another aspect, it is desirable to provide a facial mask that has at least comparable or even greater moisture or active delivery capacity than that observed with wet wipe facial masks.
In another aspect, it is necessary to provide a mask which has good adhesion to the skin and can provide a fresh feeling just like a gel-type mask.
In another aspect, it is desirable to provide a facial mask that can deliver a moisturizing effect or active to keratin materials for a long period of time and that does not retract the effect, thereby exhibiting further improvements such as hydration effects compared to wet wipe facial masks.
In another aspect, it is desirable to provide a mask that is significantly effective in improving fine wrinkles.
In another aspect, it is necessary to provide a mask that combines all of the benefits described in the above aspects.
In another aspect, the inventors have found that the concepts or principles of the present invention are applicable not only to the cosmetic field, but also to other fields, such as the medical field, and thus the mask of the above aspect may be broadened to suit (kits), which also exhibit the benefits described herein with respect to these masks.
DISCLOSURE OF THE INVENTION
The inventors have found that one particular combination may meet one or more of the above requirements, said combination comprising: 1) A first composition comprising at least one water-insoluble multivalent metal salt as an ion donor for multivalent metal, and at least one water-soluble polyhydroxy polymer; and 2) a second composition comprising at least one aqueous phase, and a) optionally, at least one water-soluble multivalent metal ion chelating agent, and b) at least one water-soluble gelling agent that forms a gel with multivalent metal ions.
One subject of the present invention is thus a kit comprising a first composition and a second composition placed separately from each other.
Another subject of the invention is a mask pack 1 comprising: 1) A first composition comprising at least one water insoluble multivalent metal salt, at least one hydroxyl-rich fiber and at least one water soluble polyhydroxy polymer, and 2) a fourth composition comprising at least one aqueous phase, and b) at least one water soluble gelling agent that forms a gel with multivalent metal ions; wherein the first composition and the fourth composition are placed apart from each other.
Another subject of the invention is the use of a second composition as a juice (tool) or part of a juice of a mask product comprising, separately from the second composition, a fabric (or towel) comprising at least one water-insoluble multivalent metal salt according to the invention.
A further subject of the invention is the use of the kit according to the invention for caring for keratin materials, in particular the skin. Such use may be represented by a method of caring for keratin materials, in particular the skin, comprising the step of compounding, in a predetermined weight ratio, the first composition and the second composition of the kit, and then applying the mixture thus obtained to the keratin materials.
A further subject of the invention is the use of a kit according to the invention for managing skin wounds, for preventing post-operative adhesion formation or for filling or repairing osteochondral defects and the like. Such use may be manifested as a method of managing skin wounds, preventing post-operative adhesion formation or filling or repairing osteochondral defects, comprising the steps of compounding the first and second compositions of the kit in a predetermined weight ratio, and then applying to a site where the mixture thus obtained is desired.
Other features and advantages of the present invention will become more apparent upon reading the following specification and examples.
Detailed Description
Except in the operating examples, or where otherwise indicated, all numbers expressing amounts of ingredients and/or reaction conditions are to be understood as being modified in all instances by the term "about", meaning within 10% of the indicated number (e.g., "about 10%" means 9% -11%, and about "2%" means 1.8% -2.2%).
The articles "a" and "an" as used herein mean one or more when applied to any feature in embodiments of the invention described in the specification and claims. The use of "a" and "an" does not limit the meaning to a single feature unless such a limit is specifically indicated. The article "the" preceding singular or plural nouns or noun phrases refers to a particular specified feature or features and may have singular or plural connotations depending upon the context in which it is used. The adjective "any" means one, some, or all, with no distinction between amounts.
The term "comprising" (and grammatical variants thereof) as used herein is used in the inclusive sense of "having" or "comprising," and not in the exclusive sense of "consisting only of …. Nevertheless, the skilled artisan will certainly appreciate that for embodiments capable of being implemented in the form of "comprising," forms "consisting essentially of …" and "consisting of …" are naturally modifications of this embodiment and are also within the scope of the invention.
All percentages and ratios are by weight unless otherwise indicated. All percentages are based on the total weight of the composition, unless otherwise indicated. The content of all components or compositions refers to the active content of the component or composition and excludes impurities, such as residual solvents or byproducts, which may be present in commercial sources.
Preferably, the "keratin material" according to the invention is skin. "skin" means whole body skin. Still preferably, the keratin material is the face or neck, especially the face.
By "topical application" is meant that the composition is applied or spread onto a surface of a keratin material, such as at least one region of the skin.
By "rinse-off" is meant a composition that is rinsed from the skin after a predetermined period of time has elapsed, such as the removal of water from the skin.
"alkali metal" means an element located in group IA of the periodic table, such as sodium, potassium, lithium, or a combination thereof, preferably sodium, potassium, or a combination thereof.
The term "water-soluble or water-dispersible" refers to a compound which, when introduced into water at 25 ℃ at a mass concentration equal to 1%, gives a macroscopically homogeneous and transparent solution, i.e. a solution having a maximum light transmission through a 1 cm thick sample of at least 60%, preferably at least 70%, at a wavelength equal to 500 nm.
In this application, unless explicitly mentioned otherwise, the amounts, parts and percentages are by weight.
According to the invention, the kit comprises a first composition and a second composition.
First composition
First, the first composition according to the present invention comprises at least one water-insoluble multivalent metal salt and at least one water-soluble polyhydroxy polymer.
Water insoluble multivalent metal salts
The term "water insoluble" means that the salt is insoluble in water, e.g. has a solubility of less than 0.01g/100g water, or only slightly soluble in water, e.g. has a solubility of less than 0.5g/100g water, and does not disintegrate into a bulk state when immersed in water.
In particular, the at least one water-insoluble multivalent metal salt may be present in the form of a powder, a microparticle, a fiber or a bulk state.
For the purposes of the present invention, the term "particulate" when used with respect to a water insoluble multivalent metal salt means that the salt is in particulate form.
In particular, the water insoluble multivalent metal salt may be formed from an acid anion and a multivalent metal cation, especially calcium, strontium, zinc, copper, manganese, aluminum, or mixtures thereof. The metal that can be used is preferably calcium, copper or a mixture thereof, more preferably calcium.
The acid providing the acid anion according to the present invention may be any known acid that can be used in cosmetics, as long as the salt formed by the acid and the polyvalent metal is water-insoluble or slightly soluble. Typical acids that may be used include various inorganic acids such as sulfuric acid, carbonic acid, phosphoric acid, metaaluminate, silicic acid, and various organic acids, especially highly saturated or unsaturated fatty acids, especially those having 18 or more carbon atoms, such as stearic acid and oleic acid, or polycarboxylic acids, especially such as alginic acid, oxalic acid, as long as the salts formed are water insoluble or sparingly soluble.
More specifically, the at least one water-insoluble multivalent metal salt may be a sulfate or alginate, preferably selected from calcium sulfate/calcium alginate, strontium sulfate/strontium alginate, zinc sulfate/zinc alginate, copper sulfate/copper alginate, manganese sulfate/manganese alginate or mixtures thereof, preferably calcium sulfate/calcium alginate or copper sulfate/copper alginate, in particular calcium sulfate/calcium alginate.
The term "alginate" particularly refers to salts of alginic acid. Alginic acid-a natural substance obtained from brown algae or from certain bacteria, is composed of two uronic acids linked together via a 1, 4-glycosidic bond: a polyuronic acid comprising beta-D-mannuronic acid (M) and alpha-L-glucuronic acid (G).
Wherein the primary cationWater-insoluble alginates containing calcium are found especially in Phaeophyceae @Phaeophyceae) In the leaf and stem of seaweed, an example of this seaweed is Fucus vesiculosus @Fucus vesiculosus) Spiral Fucus vesiculosusFucus spiralis) Algae with leaf soaking functionAscophyllum nodosum) Giant kelpMacrocystis pyrifera) Algae with wingAlaria esculenta)、Eclonia maximaThe light black giant seaweedLessonia nigrescens)、Lessonia trabeculataSea-tangleLaminaria japonica) Radix seu herba Heterophyllae AnnuaeDurvillea antarctica) Kelp in northLaminaria hyperborea) Brown algae with long-stranded algaeLaminaria longicruris) Kelp in palm shapeLaminaria digitata) Sea tangle with sugarLaminaria saccharina) Kelp of Ke's diseaseLaminaria cloustoni) AndSaragassum sp.。
suitable water insoluble alginates have a weight average molecular weight of from about 20,000 daltons to about 500,000 daltons. As in Martinsen et al, "Comparison of Different Methods for Determination of Molecular Weights and Molecular Weight Distribution of Alginates" (carbohydrate. Polym., 15, 171-193, 1991), the intrinsic viscosity is first determined and then the weight average molecular weight is calculated using the Mark-Houwink Sakurada equation.
Water-soluble polyhydroxy polymers
The term "polyhydroxy polymer" refers to a hydroxyl-containing nonionic polysaccharide.
The inventors have surprisingly found that hydroxyl-rich polymers can soften fibers, especially when the fibers are also hydroxyl-rich. By hydroxyl-rich fibers is meant herein fibers having at least 2 hydroxyl groups, preferably at least 3 hydroxyl groups, per repeat unit of the polymer of the fiber and having at least one hydroxyl-containing side chain, wherein less than 60%, preferably less than 30% or preferably less than 15% of the hydroxyl groups in the side chain are substituted.
Useful water-soluble polyhydroxy polymers include polyhydroxy carboxylic acids, acid esters; polyhydroxy cellulose; etc.
Some celluloses are known to be useful in promoting gelling behavior. Accordingly, polyhydroxy cellulose is preferably available.
In particular, nonionic polyhydroxycellulose ethers are particularly preferred, among which hydroxyalkyl celluloses, such as hydroxymethyl cellulose, hydroxyethyl cellulose (HEC) and hydroxypropyl cellulose (HPC), can be mentioned; and mixed hydroxyalkyl alkyl celluloses such as hydroxypropyl methylcellulose, hydroxyethyl ethylcellulose, and hydroxybutyl methylcellulose.
According to one embodiment, the first composition of the invention may comprise the at least one water-soluble polyhydroxy polymer in an amount of from 0.001% to 1% by weight, in particular from 0.01% to 0.1% by weight, such as from 0.01% to 0.06% by weight, relative to the total weight of the first composition.
Super absorbent material (Superabsorbent material)
According to one embodiment of the invention, the first composition may comprise at least one superabsorbent material.
In particular, the at least one superabsorbent material may be present in the form of powder, particles, fibres or in bulk state.
Superabsorbent materials advantageously exhibit a very high capacity to absorb liquids, in particular water. In particular, it may exhibit a capacity to absorb 15 times, or even 20 to 50 times, such as about 25 to 30 times, the weight of its own water.
The liquid absorption capacity of a superabsorbent material can be determined by performing the following method.
Samples of superabsorbent material in powder, fibrous or bulk state or arranged as films or sheets are weighed in the dry state (M D ). For example, square nonwoven webs having sides of about 1 centimeter (cm) can be used. In the context of the present process, the superabsorbent material is obtained in the "dry" state by treatment in a drying oven at about 50 ℃ for about 4 hours (h).
Water (or any other liquid to be absorbed by the material) is brought into contact with the material. This can be done by immersing the material in a liquid or by pouring a liquid onto the material. For example, the material may be soaked for a duration of about 1 minute (min).
Excess water (or liquid) is used, for example, to completely saturate the material. Excess water (or liquid) is then removed, for example by dripping for about 2 minutes, and the liquid-saturated material is weighed (M L )。
The difference delta between the weight of the material when saturated with liquid and the weight of the material when dry represents the amount of liquid that the material has absorbed, which weight is compared to the dry weight of the material. The value C obtained indicates the capacity of the superabsorbent material to absorb liquid, for example expressed in grams of liquid absorbed per gram of dry material:
。
the superabsorbent material may be selected from cellulose derivatives, alginates (excluding water-insoluble alginates and alkali metal alginic acid compounds described herein as water-soluble gelling agents) and derivatives thereof, in particular derivatives such as propylene glycol alginate or salts thereof, derivatives of polyacrylic or polymethacrylic acid, derivatives of poly (meth) acrylamide, derivatives of polyvinylpyrrolidone, derivatives of polyvinyl ether, mixtures thereof and the like.
In particular, the superabsorbent material may be selected from derivatives of chemically modified cellulose. For example, it may be selected from carboxymethyl cellulose, sodium carboxymethyl cellulose, carboxymethyl hydroxyethyl cellulose, carboxyethyl cellulose, hydroxyethyl ethyl cellulose, hydroxypropyl methyl cellulose, sodium methyl cellulose, microcrystalline cellulose, sodium cellulose sulfate, and mixtures thereof.
It may also be selected from alkyl celluloses. These polymers are obtained by grafting alkyl residues onto one or more hydroxyl groups of a cellulose polymer to form a hydroxyalkyl derivative. These alkyl residues may be selected from the following groups: stearyl, isostearyl, lauryl, myristyl, cetyl, isocetyl, cocoyl, palmityl, oleyl, linonyl, ricinoleyl (ricinolyl), behenyl, and mixtures thereof. These hydroxyalkyl cellulose derivatives may also be chemically modified, for example using carboxylic acid residues (carboxylic residue).
The superabsorbent materials may also be selected from natural polymer derivatives, such as gellan gum and glucomannan and galactomannan polysaccharides extracted from seeds, plant fibers, fruits, seaweed, starch, plant resins or even microbial sources. For example, it may be selected from agar gum (agar gum), guar gum, tragacanth gum, carrageenan, konjac gum, locust bean gum, gellan gum, xanthan gum and mixtures thereof.
In particular, the first composition of the invention may comprise said at least one superabsorbent material in a content of from 0% to 80% by weight, in particular from 50% to 80% by weight, or even the remaining amount (the rest), relative to the total weight of the first composition.
According to one embodiment of the invention, especially for facial mask applications, the first composition further comprises further fibers in addition to the fibers formed from the at least one water insoluble multivalent metal salt, wherein the at least one water insoluble multivalent metal salt and the at least one water soluble polyhydroxy polymer are loaded onto the further fibers.
For example, according to embodiment 1, the water-insoluble multivalent metal salt may be present in the form of fibers. The fibers of the at least one water-insoluble multivalent metal salt may then be formed into a water-insoluble substrate, either alone or with one or more other fibers. The water-soluble polyhydroxy polymer was loaded onto the substrate.
Alternatively, according to embodiment 2, the water-insoluble multivalent metal salt and the water-soluble polyhydroxy polymer may each be uniformly distributed in the water-insoluble substrate.
Water insoluble substrate
For the purposes of the present invention, the term "water-insoluble" means that the substrate is insoluble in water and does not disintegrate when immersed in water.
Embodiment 1:
generally, in this embodiment 1, the substrate may be a woven fabric or a nonwoven fabric made of fibers of the at least one water-insoluble polyvalent metal salt (hereinafter also referred to as water-insoluble polyvalent metal salt fibers) together with at least one other fiber selected from natural fibers such as cotton, pulp, bamboo and cellulose fibers, semi-natural fibers such as viscose rayon fibers, synthetic fibers such as polyester fibers, polyethylene terephthalate fibers, polyethylene fibers and polypropylene fibers. Two or more selected from other fibers may be used in combination.
The inventors have surprisingly found that hydroxyl-rich fibers can be easily softened with water-soluble polyhydroxy polymers. Thus, hydroxyl-rich fibers are preferably used according to the present invention. Such fibers may be regenerated cellulose or cotton fibers. Examples of hydroxyl-rich fibers include Viscose (Viscose), modal (Modal), lyocell (Lyocell), cupro (Cupro), cotton (Cotton), and the like.
The substrate may be formed in a wide variety of shapes and forms, such as flat pads, thick pads, sheets of irregular thickness, depending on the desired use and characteristics of the kit. By way of example only, in the case of a mask, the substrate is typically designed to conform to the area of skin where topical application is desired. For this purpose, the substrate is designed to correspond to the shape of the face, optionally avoiding the eyes, nostrils and mouth areas, when the mask is applied to the face. Non-limiting examples of substrates that can be used in the present invention are described, for example, in patent application WO 02/062132 or EP 2489286A.
According to embodiment 1, the water-insoluble multivalent metal salt is preferably formed from organic acids, especially highly saturated or unsaturated fatty acids, especially those having 18 or more carbon atoms, such as stearic acid and oleic acid, or polycarboxylic acids, such as alginic acid, oxalic acid, among others.
In particular, the water-insoluble substrate or fabric may comprise water-insoluble multivalent metal salt fibers, especially calcium alginate fibers, in an amount of 10 to 80 wt.%, especially 10 to 40 wt.%, relative to the total weight of the water-insoluble substrate or fabric. Accordingly, the water-insoluble substrate or fabric may comprise the at least one other fiber in an amount of 10 to 80 wt%, especially 50 to 80 wt%, relative to the total weight of the water-insoluble substrate or fabric.
More particularly, suitable nonwoven fabrics comprising calcium alginate fibers are commercially available from Sanjiang corporation under the name M762R-40 CN.
Embodiment 2:
alternatively, according to embodiment 2, the substrate may comprise a woven or nonwoven fabric consisting essentially of fibers selected from the group consisting of natural fibers, such as cotton, pulp, bamboo, and cellulose fibers; semi-natural fibers such as viscose rayon fibers; synthetic fibers such as at least one of polyester fibers, polyethylene terephthalate fibers, polyethylene fibers and polypropylene fibers. For such substrates, the at least one water-insoluble multivalent metal salt is distributed as uniformly as possible in the substrate.
Accordingly, water-insoluble multivalent metal salts are prepared as aqueous dispersions, for example for water-insoluble calcium salts. The dispersion is then applied to the substrate, for example, by coating, spraying, or the like, whereby the calcium salt is uniformly distributed in the substrate in an amount sufficient to form a gel with the alginate on the substrate. The wet substrate loaded with aqueous salt (aquous salt) is then dried. The method of drying the tissue is not particularly limited. For industrial applications, the wet substrate is dried in a cost effective manner.
According to another embodiment, the water-insoluble multivalent metal salt, such as a calcium salt, in solid form, e.g. as a water-insoluble salt, is crushed into a powder or particles, e.g. by milling, grinding or the like. The powder or particles are then applied uniformly to the substrate. The diameter of the powder or particles is not particularly limited as long as the water-insoluble multivalent metal salt can be uniformly distributed in the substrate in an amount sufficient to form a gel with the alginate on the substrate.
According to embodiment 2, the water-insoluble multivalent metal salt is preferably formed from an inorganic acid, for example one selected from sulfonic acid, carbonic acid, phosphoric acid, metaaluminate, silicic acid, preferably sulfonic acid.
According to embodiment 2, the water-insoluble substrate or fabric may comprise water-insoluble multivalent metal salts, in particular calcium salts, in an amount of 0.01 to 5 wt%, preferably 0.02 to 1 wt% or preferably 0.04 to 0.5 wt%, relative to the total weight of the water-insoluble substrate or fabric.
Method for bonding polyhydroxy polymers to substrates
In order to provide a softened substrate, the water soluble polyhydroxy polymer is preferably combined with a water insoluble substrate. The method of bonding the water-soluble polyhydroxy polymer to the water-insoluble substrate is not particularly limited, as long as the water-soluble polyhydroxy polymer can be uniformly distributed in the substrate in an amount sufficient to soften the substrate to a desired degree.
According to one embodiment, the water-soluble polyhydroxy polymer is prepared as an aqueous solution. The water-soluble polyhydroxy polymer was then loaded onto a substrate, such as facial tissue.
According to another embodiment, the water-soluble polyhydroxy polymer is prepared as a suspension or paste, for example, the water-soluble polyhydroxy polymer is suspended in or mixed with a non-aqueous medium to form a suspension or paste thereof. The suspension or paste is then applied to the substrate, such as by coating, spraying, or the like, so that the water-soluble polyhydroxy polymer is uniformly distributed in the substrate in an amount sufficient to form a gel with the alginate on the substrate.
In the case of applying the water-soluble polyhydroxy polymer using an aqueous solution, suspension or paste, the wet substrate loaded with the aqueous salt (aquous salt) is then dried. The method of drying the tissue is not particularly limited. For industrial applications, the wet substrate is dried in a cost effective manner.
According to yet another embodiment, the water-soluble polyhydroxy polymer in solid form is crushed into a powder or particle, such as by milling, grinding, or the like. The powder or particles are then applied uniformly to the substrate. The diameter of the powder or particles is not particularly limited as long as the water-soluble polyhydroxy polymer can be uniformly distributed in the substrate in an amount sufficient to soften the substrate.
According to the invention, the water-insoluble substrate or fabric may comprise the water-soluble polyhydroxy polymer, such as HEC or HPC, in an amount of from 0.001% to 1% by weight, especially from 0.01% to 0.1% by weight, such as from 0.01% to 0.06% by weight, relative to the total weight of the water-insoluble substrate or fabric.
The kit according to the invention comprises a second composition separate and apart from the first composition (e.g. the water insoluble substrate). The second composition is impregnated, coated or otherwise contacted with the first composition as desired to change the texture of the first composition, for example from a tissue to a gel.
Preferably, the weight ratio of the first composition (e.g., water insoluble substrate or fabric) to the second composition is from 1:3 to 1:20, preferably from 1:8 to 1:15, in order for a sufficient texture transition to occur.
Second composition
The second composition of the present invention comprises at least a) optionally, at least one water-soluble multivalent metal ion chelating agent and b) at least one water-soluble gelling agent which forms a gel with multivalent metal ions.
According to the present invention, when the first composition is mixed with the second composition, the water-insoluble multivalent metal ion donor reacts with the salt in the solution and releases multivalent metal ions. When the second composition does not comprise component a), the at least one water-soluble multivalent metal ion chelating agent, the multivalent metal ions released into the solution react directly with component b), the at least one water-soluble gelling agent. When the second composition comprises component a), the multivalent metal ions released into the solution will be largely captured by the water soluble chelating agent. A few free multivalent metal ions react in solution with the water soluble gelling agent and begin to form a gel on the towel surface. As the concentration of free multivalent metal ions decreases over time, the sequestered multivalent metal ions will gradually release, and then form a gel on the towel surface. After a short time, a transition of the tissue texture and a uniform gel on the tissue surface was observed.
Multivalent metal ion chelating agents
The second composition according to the invention comprises an optional component a), i.e. at least one water-soluble multivalent metal ion chelating agent, to promote texture transformation, in particular at least to enhance moisture or active delivery capacity. The water-soluble multivalent metal ion chelating agent is water-soluble.
According to the invention, the water-insoluble multivalent metal ion donor releases more or less multivalent metal ions into solution when the first composition is mixed with the second composition comprising component a). Both the chelating agent for the multivalent metal ion and the water-soluble gelling agent are capable of binding the multivalent metal ion.
Surprisingly, the specific chelating agents according to the invention overcome the gelling agent in competition for binding to the multivalent metal ions, such that the released multivalent metal ions are mostly captured by the water-soluble chelating agent. There are still a few free multivalent metal ions in solution that react with the water soluble gelling agent and begin to form a gel on the towel surface. As the concentration of free multivalent metal ions decreases over time, the sequestered multivalent metal ions will gradually release, and then form a gel on the towel surface. That is, the specific chelator according to the invention acts as a reservoir (reservoir) of multivalent metal ions for gel formation on the tissue surface.
Useful multivalent metal ion chelators according to the invention include aminocarboxylic acids such as ethylenediamine tetraacetic acid (EDTA), aminotriacetic acid, diethylenetriamine pentaacetic acid, in particular their alkali metal salts such as N, N-bis (carboxymethyl) glutamic acid, tetrasodium EDTA, the tetrasodium salt of N, N-bis (carboxymethyl) glutamic acid (glutamic diacetic acid, GLDA); hydroxycarboxylic acids, such as citric acid, tartaric acid, glucuronic acid, succinic acid, ethylenediamine disuccinic acid (EDDS), in particular their alkali metal salts; hydroxy amino carboxylic acids, such as hydroxyethyl ethylenediamine triacetic acid (HEDTA), dihydroxyethyl glycine (DEG), in particular their alkali metal salts; polyphosphonic acids, in particular alkali metal salts thereof; other organic acids containing phosphorus (phosphorus), such as phytic acid, in particular alkali metal salts thereof, such as sodium phytate, potassium phytate; polycarboxylic acids, such as polyacrylic acid, polymethacrylic acid, in particular their alkali metal salts.
In one embodiment, the at least one water-soluble multivalent metal ion chelating agent is an alkali metal hydroxy polycarboxylate represented by an alkane containing 1 to 4 carbon atoms, preferably containing 2 or 3 carbon atoms, substituted with 1, 2 or 3 hydroxy groups (-OH), preferably with one (1) hydroxy group, and further with 2, 3, 4 or 5 carboxylic acid/carboxylate groups (-COOM), preferably with 2 or 3 carboxylic acid/carboxylate groups (-COOM), wherein a plurality of groups M independently represent H or an alkali metal, provided that at least one group M represents an alkali metal, such as Na, K or Li, preferably all groups M represent an alkali metal, such as Na, K or Li, preferably Na. More specifically, the at least one alkali metal hydroxypolycarboxylate may be selected from sodium tartrate, sodium citrate, potassium tartrate, potassium citrate and hydrates thereof, preferably sodium citrate, in particular trisodium citrate. Sodium citrate is used herein to refer to monosodium citrate, disodium citrate, and trisodium citrate, and other alkali metal hydroxy polycarboxylates may be understood in a similar manner.
The alkali metals mentioned above are particularly preferably sodium or potassium, in particular sodium. Accordingly, preferred chelating agents may include sodium citrate, tetrasodium EDTA, tetrasodium GLDA, trisodium EDDS, sodium phytate, or mixtures thereof.
In particular, the second composition of the invention may comprise the at least one water-soluble multivalent metal ion chelating agent in an amount of 0.1 to 1 wt. -%, in particular 0.2 to 0.4 wt. -%, relative to the total weight of the second composition.
Water-soluble gelling agent
The second composition according to the invention comprises at least one water-soluble gelling agent which can form a gel with multivalent metal ions to induce a texture transition.
In the present application, the term "water-soluble gelling agent" particularly refers to a gelling agent that can form a gel with the multivalent metal ions from the first composition.
According to the invention, the water-insoluble multivalent metal ion donor releases more or less multivalent metal ions into the solution when the first composition is mixed with the second composition.
In accordance with the principles of the present invention, the gelling agent may thus be any gelling agent that can form a gel with multivalent metal ions. Examples of gelling agents may include gelatin proteins, pectins, gellan gum, carrageenan, agar, alginic acid compounds, in particular alkali metal salts of alginic acid, such as sodium alginate, and mixtures thereof. When the second composition comprises component a), i.e. the chelating agent, the gelling agent and the chelating agent are specifically selected, wherein the gelling agent has a lower capacity to bind to multivalent metal ions than the chelating agent does to bind to multivalent metal ions, such that the gelling agent does not bind to free multivalent metal ions released directly from the first composition, but to multivalent metal ions released subsequently from the reservoir (reservoir), i.e. the chelated multivalent metal ions. Accordingly, a gel may be formed on the surface of the first composition.
Pectin is a linear polymer of alpha-D-galacturonic acid (at least 65%) linked in the 1-and 4-positions to a proportion of carboxylic acid groups esterified with methanol groups. About 20% of the sugars constituting the pectin molecule are neutral sugars (L-rhamnose, D-glucose, D-galactose, L-arabinose, D-xylose). L-rhamnose residues are found in all pectins and are incorporated in the backbone in the 1,2 position.
The uronic acid molecule carries a carboxyl function. When they are COO - In its form, this functionality imparts ion exchange capacity to pectin. Divalent ions, in particular calcium, have the ability to form an ionic bridge between two carboxyl groups of two different pectin molecules.
In the natural state, a proportion of the carboxyl groups are esterified with methanol groups. The natural degree of esterification of pectin can be between 70% (apple, lemon) and 10% (strawberry), depending on the source used. With pectin having a high degree of esterification, it is possible to hydrolyze-COOCH 3 Groups to obtain weakly esterified pectin. Depending on the proportion of methylated or unmethylated monomers, the chains are therefore more or less acidic. HM (high methoxy) pectin is thus defined as having a degree of esterification of more than 50% and LM (low methoxy) pectin is defined as having a degree of esterification of less than 50%.
In the case of amidated pectins, -OCH 3 The radical being-NH 2 And (3) group substitution.
Pectin is sold by, inter alia, cargill under the name Uninectine ™, CP-Kelco under the name Genu and Danisco under the name Grinsted Pectin.
Carrageenan is an anionic polysaccharide that constitutes the cell wall of various red algae (Rhodophyceae) belonging to the families of the huperziaceae (gigartinaceae), sha Caike (hypneceae), furseliaceae (furselariaceae) and polysaccharidaceae (polysaccharidae). They are typically obtained by hot water extraction from natural strains of the algae. These linear polymers formed from disaccharide units consist of two D-galactopyranose units, which are alternately linked by alpha (1, 3) and beta (1, 4) linkages. They are highly sulfated polysaccharides (20-50%) and the α -D-galactopyranosyl residues may be in 3, 6-anhydro form. Several types of carrageenans are distinguished by the number and position of sulfate groups on the repeating disaccharide of the molecule, namely: kappa carrageenan with one sulfate group, iota carrageenan with two sulfate groups and lambda carrageenan with three sulfate groups.
Carrageenan consists essentially of the potassium, sodium, magnesium, triethanolamine and/or calcium salts of the polysaccharide sulfate.
Carrageenan is especially available from SEPPIC company as Solagum ® Named, by Gelymar company under Carragel ® 、Carralact ® And Carrasol ® Named by Cargill under the names Satiagel ™ and Satiagel ™, and by CP-Kelco under the name Genulocta ® 、Genugel ® And Genuvisco ® Is sold for the name.
Agar is a galactose polysaccharide contained in the cell walls of some of the red algae (rhodophyceae) of these species. They are formed from polymeric groups whose basic backbone is beta (1, 3) D-galactopyranose and alpha (1, 4) L3-6 anhydrogalactose chains, these units being repeated regularly and alternately. Differences within the agar family are attributed to the presence or absence of solvated methyl or carboxyethyl groups. These hybrid structures are typically present in variable percentages, depending on the species of algae and the harvest season.
Agar is present at 40,000 to 300,000 g.mol -1 A mixture of high molecular mass polysaccharides (agarose and sepharose). By preparing an algae extract, typically by autoclaving, and by treating an extract containing approximately 2% agarThese liquids are obtained by extracting agar.
Agar is for example produced by B & V Agar generators groups under the name Gold Agar, by Hispar company under the names Agarite and Grand Agar, and by Setexam company under the names Agar-Agar, QSA (Quick Soluble Agar) and Puragar.
Gellan gum is an anionic linear heteropolyglycoside based on an oligoglycoside (oligoside) unit consisting of 4 sugars. D-glucose, L-rhamnose and D-glucuronic acid in a ratio of 2:1:1 are present in the gellan gum in the form of monomer units (monomer elements).
For example sold by CP Kelco under the name Kelcogel CG LA.
In one embodiment of the invention, the gelling agent is preferably selected from alkali metal alginic acid compounds. Particularly preferred gelling agents are alginates, such as sodium or potassium alginate, especially sodium alginate.
According to one embodiment, the at least one water-soluble gelling agent is present in the second composition in 0.1 to 0.5 wt%, preferably 0.1 to 0.3 wt%, relative to the total weight of the second composition.
According to the invention, the amounts of chelating agent and gelling agent are selected such that the molar ratio of the portion of chelating agent that is sequesterable with multivalent cations to the portion of gelling agent that is releasable with multivalent cations to form a gel is from about 10:1 to about 1:1, preferably from about 5:1 to about 2:1.
Alkali metal alginic acid compound
The term "alkali metal alginate compound" refers in particular to alkali metal alginate (alginate) or alkali metal salts of alginic acid derivatives. The alkali metal alginic compound is water soluble.
Alginic acid-a natural substance obtained from brown algae or from certain bacteria, is composed of two uronic acids linked together via a 1, 4-glycosidic bond: a polyuronic acid comprising beta-D-mannuronic acid (M) and alpha-L-glucuronic acid (G).
Alginic acid can form water-soluble salts (alginates) with alkali metals such as sodium, potassium or lithium. These alginates are water soluble in aqueous media at pH 4, but dissociate into alginic acid at a pH below 4.
Methods for recovering these water-soluble salts, particularly sodium alginate, from natural sources are well known and are described, for example, in Green, U.S. patent No. 2,036,934 and Le Gloahec, U.S. patent No. 2,128,551.
Alginic acid or alginate may be chemically modified, especially with urea or urethane groups, or by hydrolysis, oxidation, esterification, etherification, sulfation (sulfation), phosphorylation (phosphorylation), amination, amidation or alkylation reactions, or by several of these modifications, to form alginic acid derivatives, including salts.
These derivatives may be anionic, cationic, amphoteric or nonionic and are capable of forming water soluble salts with alkali metals, such as sodium, potassium or lithium, to form alkali metal salts of alginic acid derivatives.
More specifically, the alginate may be reacted with an alkylene oxide, such as ethylene oxide or propylene oxide, to form a polyglycol alginate (polyglycol alginates). The polyglycol segment is bonded to the alginate via one or more carboxyl groups. Typically, alginate reacts with propylene oxide to form polypropylene glycol alginate (PPG alginate), and ethylene oxide to form polyethylene glycol alginate (PEG alginate). The preparation of polyglycol alginate is disclosed in Strong, U.S. Pat. No. 3,948,881, pettitt, U.S. Pat. No. 3,772,266 and Steiner, U.S. Pat. No. 2,426,125.
Preferably, the polyglycol alginate has a degree of esterification of from about 40% to about 95%, more preferably from about 70% to 95%.
Suitable alginates have a weight average molecular weight of from about 20,000 daltons to about 500,000 daltons. As in Martinsen et al, "Comparison of Different Methods for Determination of Molecular Weights and Molecular Weight Distribution of Alginates" (carbohydrate. Polym., 15, 171-193, 1991), the intrinsic viscosity is first determined and then the weight average molecular weight is calculated using the Mark-Houwink Sakurada equation.
The weight average molecular weights indicated above also apply to the alkali metal salts of alginic acid derivatives.
A list of various commercially available alginates, their nature and their sources can be found in Shapiro, U.S. Pat. No. 6,334,968, table 1, column 16, line 49 through column 17, line 18, incorporated herein by reference.
According to one embodiment of the present invention, the alkali metal alginic compound may be selected from sodium alginate and potassium alginate, preferably sodium alginate.
Representative of alkali metal alginic acid compounds suitable for use in the present invention may be, for example, cargill Products company under the name Kelcosol, satialgine ™, cecalgum ™ or Alogel ™, FMC biopolymers company under the name Protanal ™, danisco company under the name Grindsed ® Alginate is named, kimica Algin is named and ISP is Manucol ® And Manugel ® Products sold for the name.
Aqueous phase
The second composition according to the invention comprises at least one aqueous phase.
The at least one aqueous phase comprises water.
The aqueous phase may also comprise water-miscible organic solvents (at room temperature: 25 ℃) such as monoalcohols containing from 2 to 6 carbon atoms, for example ethanol or isopropanol; in particular polyols having 2 to 20 carbon atoms, preferably having 2 to 10 carbon atoms, preferably having 2 to 6 carbon atoms, such as glycerol, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, dipropylene glycol or diethylene glycol; glycol ethers (especially containing 3 to 16 carbon atoms), such as mono-, di-or tri-propylene glycol (C) 1 -C 4 ) Alkyl ethers, mono-, di-or tri-ethylene glycol (C) 1 -C 4 ) Alkyl ethers, and mixtures thereof.
The aqueous phase may also comprise any water-soluble or water-dispersible compound compatible with the aqueous phase, such as hydrophilic gelling agents, preservatives or surfactants, and mixtures thereof.
In particular, the second composition of the invention may comprise said at least one aqueous phase in a content of from 10% to 99% by weight, in particular from 50% to 99% by weight, more in particular from 70% to 99% by weight, relative to the total weight of the second composition.
Hydrophilic gelling agents
The second composition according to the invention may optionally comprise at least one additional hydrophilic gelling agent.
For the purposes of the present invention, the term "hydrophilic gelling agent" refers to a compound that is capable of gelling the aqueous phase without binding to the multivalent metal ions from the first composition.
The gelling agent may be water-soluble or water-dispersible.
More specifically, the hydrophilic gelling agent may be selected from synthetic polymeric gelling agents, polymeric gelling agents of natural or natural origin, or mixtures thereof.
Synthetic polymeric gellants
For the purposes of the present invention, the term "synthetic" means that the polymer is not a derivative of a naturally occurring or not naturally derived polymer.
The synthetic polymeric gellants contemplated according to the present invention may or may not be microparticles.
For the purposes of the present invention, the term "microparticle" when used in the synthesis of a polymeric gellant means that the polymer is in the form of particles, preferably spherical particles.
More specifically, these polymers may be chosen, inter alia, from:
modified or unmodified carboxyvinyl polymers, e.g. Carbopol from Goodrich ® (CTFA name: carbomer) products sold under the name; polyacrylates, polymethacrylates, e.g. from Guardian under the name Lubrajel ™ and Norgel or from Hispo Chimica under the name Hispagel ® Products sold for name; polyacrylamide; optionally crosslinked and/or neutralized 2-acrylamido-2-methylpropanesulfonic acid polymers and copolymers, e.g. from Clariant company as Hostacein AMPS ® Poly (2-acrylamido-2-methylpropanesulfonic acid) (CTFA name: ammonium polyacryl dimethyl taurate (ammonium polyacryldimethyltauramide)) sold by name; acrylamide and AMPS ® In the form of a W/O emulsion, such as that sold by the company SEPPIC under the name Sepigel ™ 305 (CTFA name: poly)acrylamide/C 13-14 Isoparaffin/laureth-7) and under the name Simulgel ™ 600 (CTFA name: acrylamide/sodium acryloyldimethyl taurate copolymer/isohexadecane/polysorbate 80); and mixtures thereof.
Preferably, these polymers may be selected from acrylates/acrylic acid C 10-30 Alkyl ester crosslinked polymers, e.g. Carbopol ® ultrez 20、Carbopol ® ultrez 21、Permulen™ TR-1、Permulen™ TR-2、Carbopol ® 1382、Carbopol ® ETD 2020, carbomers, e.g. Synthalen ® K、Carbopol ® 980. Ammonium acryloyldimethyl taurate/steareth-8 methacrylate copolymers, e.g. Aristoflex ® SNC, acrylate copolymers, e.g. Carbopol ® Aqua SF-1, ammonium acryloyldimethyl taurate/steareth-25 methacrylate cross-linked polymers, e.g. Aristoflex ® HMS, ammonium acryloyldimethyl taurates, e.g. Aristoflex ® AVC。
Preferably, these polymers may be selected from carboxyvinyl polymers, such as Carbopol ® Products (carbomers), e.g. Carbopol sold by Lubrizol ® Ultrez 20 Polymer, and Pemulen product (acrylate/acrylic acid C 10-30 Alkyl ester copolymers); polyacrylamide, e.g. SEPPIC under the trademark Sepigel ™ 305 (CTFA name: polyacrylamide/C) 13-14 Isoparaffin/laureth-7) or Simulgel ™ 600 (CTFA name: acrylamide/sodium acryloyldimethyl taurate copolymer/isohexadecane/polysorbate 80); optionally crosslinked and/or neutralized 2-acrylamido-2-methylpropanesulfonic acid polymers and copolymers, e.g. Hoechst under the trademark Hostacein AMPS ® (CTFA name: ammonium polyacryl dimethyltaurate) sold as poly (2-acrylamido-2-methylpropanesulfonic acid) or Simulgel ™ sold as SEPPIC (CTFA name: sodium polyacryl dimethyltaurate/polysorbate 80/sorbitan oleate); copolymers of 2-acrylamido-2-methylpropanesulfonic acid and hydroxyethyl acrylate, such as Simulgel ™ NS and Sepinov EMT 10 sold by SEPPIC; and mixtures thereof.
Preferably, these polymers may be selected from the group of glyceride/acrylic acid copolymers available from ISP Technologies, inc (United guard inc.) under the trade name Lubrajel ™, in particular in the form of what is known as Lubrajel ™ oil, which contains from about 1.0% to 1.3% of the glyceride/acrylic acid copolymer in an aqueous solution of glycerol (about 40% glycerol). Lubrajel ™ oil also included about 0.6% PVM/MA copolymer (also known as methoxyethylene/maleic anhydride copolymer).
Polymeric gellants of natural or natural origin
For the purposes of the present invention, the term "naturally derived" is intended to mean a polymeric gellant obtained by modification of a natural polymeric gellant.
These gelling agents may be particulate or non-particulate.
More specifically, these gelling agents belong to the class of polysaccharides.
In general, the polysaccharides suitable for use in the present invention may be homopolysaccharides, if polysaccharides, glucans, galactans and mannans, or heteropolysaccharides, such as hemicellulose.
Similarly, they may be linear polysaccharides, such as pullulan, or branched polysaccharides, such as gum arabic and pullulan, or mixed polysaccharides, such as starch.
In general, the polysaccharide may be selected from polysaccharides produced by microorganisms; polysaccharides isolated from algae, and higher plant polysaccharides, such as homogeneous polysaccharides, in particular cellulose and its derivatives or levans, heterogeneous polysaccharides, such as gum arabinles, galactomannans, glucomannans and its derivatives; and mixtures thereof.
In particular, the polysaccharide may be selected from the group consisting of fructans, gellans, glucans, amylose, amylopectin, glycogen, pullulan, dextran, cellulose and derivatives thereof, in particular methylcellulose, hydroxyalkyl cellulose, ethylhydroxyethyl cellulose and carboxymethyl cellulose, mannans, xylans, lignin, arabinans, galactans, polygalacturonic acid (galacturonans), chitin, chitosan, glucuronoxylans (glucoronans), arabinoxylans, xyloglucans, glucomannans, arabinogalactans, glycosaminoglycans (glycosaminoglucans), gum arable, tragacanth, ghatti gum, locust bean gum, galactomannans, such as guar gum and nonionic derivatives thereof, in particular hydroxypropyl guar gum and ionic derivatives thereof, biopolysaccharide gums of microbial origin (biopoly saccharide gums), in particular scleroglucan or xanthan gum, mucopolysaccharides, in particular chondroitin sulfate, and mixtures thereof. These polysaccharides may be chemically modified, in particular with urea or urethane groups, or by hydrolysis, oxidation, esterification, etherification, sulfation (sulfation), phosphorylation (phosphonation), amination, amidation or alkylation reactions, or by several of these modifications.
The resulting derivatives may be anionic, cationic, amphoteric or nonionic.
Advantageously, the polysaccharide may be selected from xanthan gum, scleroglucan gum, guar gum, inulin and pullulan, and mixtures thereof.
In general, such compounds useful in the present invention are selected from those described in particular in the following documents: kirk-Othmer's Encyclopedia of Chemical Technology, third edition, 1982, volume 3, pages 896-900 and volume 15, pages 439-458; polymers in Nature by E.A. MacGregor and C.T. Greenwood, published by John Wiley & Sons, chapter 6, pages 240-328, 1980; books entitled Handbook of Water-Soluble Gums and Resins by Robert L.Davidson, published by McGraw Hill Book Company (1980) and by Industrial gumms-Polysaccharides and their Derivatives, roy L.Whistler, second edition, academic Press Inc.
Rather, these polysaccharides suitable for use in the present invention can be distinguished according to whether they are derived from microorganisms, from algae or from higher plants, and are described in detail below.
Polysaccharides produced by microorganisms
Xanthan gum
Xanthan gum isOn an industrial scale by the bacterium Xanthomonas campestris Xanthomonas campestris) Is produced by aerobic fermentation. Like cellulose, its structure consists of a backbone of beta (1, 4) -linked beta-D-glucose. One of the two glucose molecules carries a trisaccharide side chain consisting of α -D-mannose, β -D-glucuronic acid and terminal β -D-mannose. The internal mannose residues are typically acetylated at carbon 6. About 30% of the terminal mannose residues bear pyruvate groups attached in chelate form between carbon 4 and carbon 6. Charged pyruvic acid and glucuronic acid are ionizable and therefore responsible for the anionic nature of xanthan (negative charge down to a pH equal to 1). The content of pyruvate and acetate residues varies depending on the strain, fermentation process, conditions after fermentation and purification steps. These groups are useful in commercial products as Na + 、K + Or Ca 2+ Ion neutralization (Satia, inc., 1986). The neutralized form can be converted to the acid form by ion exchange or by dialysis from an acidic solution.
Xanthan gum has a molecular weight between 1 000 000 and 50 000 000 and a viscosity between 0.6 and 1.65 pa.s for an aqueous composition containing 1% xanthan gum (measured at 25 ℃ on a LVT-type brookfield viscometer at 60 rpm).
Representative of xanthan gum are, for example, rhodia Chimie under the name Rhodicare, cargill Texturizing Solutions under the name Satiaxane ™ (for the food, cosmetic and pharmaceutical industries), ADM under the name Novaxan ™ and CP-Kelco under the name Kelzan ® And Keltrol ® Products sold for the name.
Pullulan polysaccharide
Pullulan is a polysaccharide composed of maltotriose units, known by the name α (1, 4) - α (1, 6) -glucan. Three glucose units in maltotriose are linked via an alpha (1, 4) glycosidic bond, while successive maltotriose units are linked to each other via an alpha (1, 6) glycosidic bond.
Pullulan is produced, for example, by the Hayashibara group of japan under the designation Pullulan PF 20.
Dextran and dextrorotationDextran sulfate
Dextran is a neutral polysaccharide without any charged groups, which is biologically inert, prepared by fermentation of sugar beet sugar containing only hydroxyl groups. Dextran fractions of different molecular weights can be obtained from natural dextran by hydrolysis and purification. Dextran may be in particular in the form of dextran sulfate.
Dextran is represented by, for example, the products sold by the company Phacosmos under the names Dextran or Dextran T, or by the company Meito Sangyo Co., under the names Dextran 40 Powder or Dextran 70 Powder. Dextran sulfate is sold by PK Chemical A/S under the name Dextran sulfate.
Succinoglycan
Succinoglycan is a high molecular weight extracellular polymer produced by bacterial fermentation, consisting of eight sugar repeating units (8 sugar repeats). Succinoglycans are sold, for example, by Rhodia under the name Rheozan.
Scleroglucan
Scleroglucan is a nonionic branched homopolysaccharide consisting of β -D-glucan units. The molecule consists of a linear backbone formed of D-glucose units linked via β (1, 3) linkages, and wherein one third is linked to a pendant D-glucose unit via β (1, 6) linkages.
A more complete description of scleroglucan and its preparation can be found in patent US 3 301 848.
Scleroglucan is sold, for example, by Alban Miiller under the name Amigel or by Cargill under the name Actigum ™ CS.
Polysaccharide isolated from algae
Alternaria alternata (L.) Gaertn
Furcellaran is commercially available from red algae furcellaran (Furcellaria fasztigiata). Furcellaran is produced, for example, by Est-Agar corporation.
Polysaccharides of higher plants
Polysaccharides of this class can be divided into homogeneous polysaccharides (only one saccharide) and heterogeneous polysaccharides consisting of several types of saccharides.
a) Homogeneous polysaccharide and derivatives thereof
The polysaccharide according to the invention may be selected from cellulose and derivatives or levan.
Cellulose and derivatives
The polysaccharide according to the invention may also be cellulose or a derivative thereof, in particular a cellulose ether or ester (e.g. methylcellulose, carboxymethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxymethylpropylcellulose, cellulose acetate, nitrocellulose).
The present invention may also contain a cellulose-based associative polymer.
According to the present invention, the term "cellulose-based compound" refers to any polysaccharide compound having in its structure a linear sequence of anhydroglucopyranose residues (AGU) linked together via β (1, 4) bonds. The repeating units are cellobiose dimers. AGU is in a chair conformation and bears 3 hydroxyl functions: 2 secondary alcohols (at positions 2 and 3) and one primary alcohol (at position 6). The polymers thus formed are bound together via intermolecular bonds of the hydrogen bonding type, thus providing the cellulose with a fibrous structure (about 1500 molecules per fiber).
Depending on the source of the cellulose, the degree of polymerization varies greatly; the value thereof may be several hundred to several tens of thousands.
The hydroxyl groups of cellulose may be partially or fully reacted with various chemical reagents to produce cellulose derivatives having inherent properties. The cellulose derivative may be anionic, cationic, amphoteric or nonionic. Among these derivatives, cellulose ethers, cellulose esters and cellulose ester ethers are distinguished.
Among the nonionic cellulose ethers, alkyl celluloses, such as methyl cellulose and ethyl cellulose, can be mentioned; hydroxyalkyl celluloses such as hydroxymethyl cellulose, hydroxyethyl cellulose and hydroxypropyl cellulose; and mixed hydroxyalkyl alkyl celluloses such as hydroxypropyl methylcellulose, hydroxyethyl ethylcellulose, and hydroxybutyl methylcellulose.
According to the invention, hydroxyalkyl cellulose belongs to the class of nonionic polysaccharides as nonionic cellulose ethers, so that it can be used as a water-soluble polyhydroxy polymer to soften hydroxyl-rich fibers. Thus, according to one embodiment of the invention, the first composition comprises hydroxyl-rich fibers and the second composition comprises hydroxyalkyl cellulose.
Among the anionic cellulose ethers, mention may be made of carboxyalkyl celluloses and salts thereof. For example, carboxymethyl cellulose, carboxymethyl methylcellulose and carboxymethyl hydroxyethyl cellulose and sodium salts thereof may be mentioned.
Among the cationic cellulose ethers, mention may be made of crosslinked or uncrosslinked quaternized hydroxyethyl cellulose.
The quaternizing agent can be, in particular, glycidyl trimethylammonium chloride or fatty amines, such as laurylamine or stearylamine. Another cationic cellulose ether that may be mentioned is hydroxyethyl cellulose hydroxypropyl trimethylammonium.
Quaternized cellulose derivatives are in particular:
quaternized cellulose modified with groups containing at least one fatty chain, such as alkyl, arylalkyl or alkylaryl groups containing at least 8 carbon atoms, or mixtures thereof,
quaternized hydroxyethylcellulose modified with groups comprising at least one fatty chain, such as alkyl, arylalkyl or alkylaryl groups comprising at least 8 carbon atoms, or mixtures thereof.
The alkyl groups carried by the quaternized cellulose or hydroxyethyl cellulose described above preferably contain 8 to 30 carbon atoms. Aryl preferably means phenyl, benzyl, naphthyl or anthracyl.
Pointed out to contain C 8-30 Examples of quaternized alkyl hydroxyethyl cellulose of the fatty chain include the products Quattrisoft LM 200, quattrisoft LM-X529-18-A, quattrisoft LM-X529-18B (C) 12 Alkyl) and Quattrisoft LM-X529-8 (C) 18 Alkyl), and products sold by Croda company Crodacel QM, crodacel QL (C) 12 Alkyl) and Crodacel QS (C 18 Alkyl).
Among the cellulose derivatives, mention may also be made of:
cellulose modified with groups comprising at least one fatty chain, for example with groups comprising at least one fatty chain, such as alkyl groups, in particular C 8-22 Alkyl, arylalkyl and alkylaryl modified hydroxyethylcellulose, e.g. Natrosol Plus Grade 330 CS (C 16 Alkyl), and
cellulose modified with polyalkylene glycol alkylphenyl ether groups, such as product Amercell Polymer HM-1500 (nonylphenyl polyethylene glycol (15) ether) sold by Amerchol.
Cellulose esters include inorganic cellulose esters (cellulose nitrate, sulfate, phosphate, etc.), organic cellulose esters (cellulose monoacetate, triacetate, amidopropionate, acetate butyrate, acetate propionate, acetate trimellitate, etc.), and mixed organic/inorganic cellulose esters such as cellulose acetate butyrate and cellulose acetate propionate. Among the cellulose ester ethers, hydroxypropyl methylcellulose phthalate and ethylcellulose sulfate may be mentioned.
The cellulose-based compounds of the present invention may be selected from unsubstituted cellulose and substituted cellulose. Representative of cellulose and derivatives are, for example, FMC Biopolymers Inc. Avicel ® (microcrystalline cellulose, MCC) under the name Noviant (CP-Kelco) under the name Cekol (carboxymethyl cellulose), akzo Nobel under the name Akucell AF (sodium carboxymethyl cellulose), dow under the name Methocel ™ (cellulose ether) and Ethocel ™ (ethyl cellulose), and Hercules Aqualon under the name Aqualon ® (carboxymethyl cellulose and sodium carboxymethyl cellulose), benicel ® (methyl cellulose), blance ™ (carboxymethyl cellulose), culminal ® (methylcellulose, hydroxypropyl methylcellulose), klucel ® (hydroxypropyl cellulose), polysurf ® (cetyl hydroxyethylcellulose) and Natrosol ® CS (hydroxyethyl cellulose) is a product sold under the name.
Levan
The polysaccharides according to the invention may in particular be fructans selected from inulin and derivatives thereof (in particular dicarboxylic inulin and carboxymethyl inulin).
Fructans or fructans are oligosaccharides or polysaccharides comprising a sequence of anhydrofructose units optionally in combination with several sugar residues other than fructose. Levan may be linear or branched. Levan may be a product obtained directly from plant or microbial sources, or a product whose chain length has been modified (increased or decreased) by fractionation, synthesis or hydrolysis, in particular by enzymatic means. Levan generally has a degree of polymerization of 2 to about 1000, preferably 2 to about 60.
Three classes of levan are distinguished. The first corresponds to products whose fructose units are mostly linked via a β (2, 1) linkage. These are essentially linear fructans, such as inulin.
The second class also corresponds to linear fructose, but the fructose units are essentially linked via β (2, 6) linkages. These products are levans (levans).
The third class corresponds to mixed levans, i.e., containing β (2, 6) and β (2, 1) sequences. These are essentially branched fructans, such as rye polyfructose (graminans).
The preferred levan in the composition according to the invention is inulin. Inulin may be obtained, for example, from chicory, dahlia or Jerusalem artichoke (Jerusalem artichoke), preferably from chicory.
In particular, polysaccharides, in particular inulin, have a degree of polymerization of 2 to about 1000, preferably 2 to about 60, and a degree of substitution of less than 2 on the basis of one fructose unit.
Representative of inulin for use in the present invention are, for example, orafti under the name Beneo ™ inulin, and Sensus under the name Frutafit ® Products sold for the name.
b) Heterogeneous polysaccharide and derivatives thereof
The polysaccharide which may be used according to the invention may be a gum such as cassia, karaya, konjac, tragacanth, tara, acacia or acacia.
Gum arabic
Gum arabic is a highly branched acidic polysaccharide in the form of a mixture of potassium, magnesium and calcium salts. The monomeric units of the free acid (Arabic acid) are D-galactose, L-arabinose, L-rhamnose and D-glucuronic acid.
Galactomannans (guar gum, locust bean gum, fenugreek gum, tara gum) and derivatives (guar phosphate esters, hydroxypropyl guar, etc.)
Galactomannans are nonionic polyglycosides extracted from the endosperm of leguminous seeds, which constitute the storage carbohydrate of leguminous seeds.
Galactomannans are macromolecules composed of a backbone of β (1, 4) -linked D-mannopyranose units with side branches composed of a single D-galactopyranose unit, which is α (1, 6) linked to the backbone. The various galactomannans differ firstly in the proportion of alpha-D-galactopyranose units present in the polymer and secondly in the significant differences in the distribution of galactose units along the mannose chains.
Guar gum has a mannose/galactose (M/G) ratio of about 2, tara gum has a mannose/galactose (M/G) ratio of 3, and locust bean gum has a mannose/galactose (M/G) ratio of 4.
Guar gum
Guar gum is characterized by a mannose/galactose ratio of about 2/1. Galactose groups are regularly distributed along the mannose chains.
Guar gum which can be used according to the invention can be nonionic, cationic or anionic. According to the present invention, chemically modified or unmodified nonionic guar can be used.
Unmodified nonionic guar gum is, for example, unipecine under the name Vidogum GH, vidogum G and Vidocrem and Rhodia under the name Jaguar, danisco under the name Meypro ® Guar is named, cargill is named Viscogma ™ and Aqualon is named Supercol ® Guar gum is a product sold under the name guar gum.
Representative of hydrolyzed nonionic guar gum which can be used according to the present invention are, for example, the company Danisco with Meypror ® Products sold for the name.
Modified nonionic guar usable according to the invention is preferably C 1 -C 6 Hydroxyalkyl modifications, among which mention may be made of, for example, hydroxymethyl, hydroxyethyl, hydroxypropyl and hydroxybutyl.
Such nonionic guar optionally modified with hydroxyalkyl groups are known, for example, from Rhodia under the trade names Jaguar HP 60, jaguar HP 105 and Jaguar HP 120 (hydroxypropyl guar) or Aqualon under the N-Hance ® HP (hydroxypropyl guar) is sold under the name.
The cationic galactomannan gum preferably has a cationic charge density of less than or equal to 1.5 meq/g, more particularly between 0.1 and 1 meq/g. The charge density can be determined by the Kjeldahl method. Which generally corresponds to a pH of about 3 to 9.
Generally, for the purposes of the present invention, the term "cationic galactomannan gum" refers to any galactomannan gum containing cationic groups and/or groups ionizable into cationic groups.
Preferred cationic groups are selected from those comprising primary, secondary, tertiary and/or quaternary amine groups.
The cationic galactomannan gum used typically has a molecular weight of between about 500 and 5 x 10 6 Between, preferably about 10 3 Up to 3X 10 6 Weight average molecular mass in between.
Cationic galactomannan gums which can be used according to the present invention are, for example, those comprising tri (C) 1-4 ) Gums of alkylammonium cationic groups. Preferably, 2% to 30% of the hydroxyl functional number of these gums bears trialkylammonium cationic groups.
Among these trialkylammonium groups, mention may most particularly be made of trimethylammonium and triethylammonium groups.
More preferably, these groups represent 5 to 20% by weight relative to the total weight of the modified galactomannan gum.
According to the invention, the cationic galactomannan gum is preferably guar gum comprising hydroxypropyl trimethylammonium groups, i.e. guar gum modified with 2, 3-epoxypropyl trimethylammonium chloride, for example.
These galactomannan gums, in particular guar gums modified with cationic groups, are products known per se and are described, for example, in the patents US 3 589 578 and US 4 031 307. Furthermore, these products are known in particular from Rhodia under the trade names Jaguar EXCEL, jaguar C13S, jaguar C15, jaguar C17 and Jaguar CI 62 (guar hydroxypropyl trimethylammonium chloride), from Degussa under the Amilan name ® Guar (Guar hydroxypropyl trimethyl ammonium chloride) is named and is available from Aqualon corporation as N-Hance ® 3000 (guar hydroxypropyl trimethylammonium chloride) is sold under the name.
Anionic guar useful according to the present invention is a polymer comprising groups derived from carboxylic, sulfonic, sulfenamic, phosphoric, phosphonic or pyruvic acids. The anionic groups are preferably carboxylic acid groups. The anionic groups may also be in the form of acid salts, in particular sodium, calcium, lithium or potassium salts.
The anionic guar which can be used according to the invention is preferably a carboxymethyl guar derivative (carboxymethyl guar or carboxymethyl hydroxypropyl guar).
Locust bean gum
Locust bean gum is extracted from the seeds of locust bean tree carob (Ceratonia siliqua).
Unmodified locust bean gum which can be used in the present invention is for example named Viscogn ™ by Cargill company, vidogum L by Unipektin company and Grisco by Grinsted by Danisco company ® LBG is sold under the name.
Representative of chemically modified locust bean gum useful in the present invention may be, for example, cationic locust bean gum sold by the company Toho under the name of Catinal CLB (locust bean gum hydroxypropyl trimethylammonium chloride).
Tara adhesive
Tara gums useful in the context of the present invention are sold, for example, by Unipektin under the name Vidougum SP.
Glucomannan (konjak gum)
Glucomannans are polysaccharides of high molecular weight (500 000 < M glucomannans < 2 000 000) consisting of D-mannose and D-glucose units, with about one branch per 50 or 60 units. It is present in wood but is also the main component of konjac glucomannan. Konjak (Amorphophallus konjac) is a plant of the Araceae family.
The products which can be used according to the invention are, for example, those available from Shimizu corporation under the Propol name ® And Rheolex ® Is sold for the name.
Other polysaccharides
Among the other polysaccharides which can be used according to the invention, mention may also be made of chitin (poly-N-acetyl-D-glucosamine, beta (1, 4) -2-acetamido-2-deoxy-D-glucose), chitosan and derivatives (chitosan-beta-glycerophosphate, carboxymethyl chitin, etc.), such as those sold by franke-chitosan company; glycosaminoglycans (GAGs) such as hyaluronic acid, chondroitin sulfate, dermatan sulfate, keratan sulfate, preferably hyaluronic acid; xylan (or arabinoxylan) and derivatives.
Arabinoxylans are polymers of xylose and arabinose, both classified under the pentosan name. Xylan consists of a backbone of β (1, 4) -linked D-xylose units, and three substituents are present thereon (Rouau & Thibault, 1987): the acid unit, α -L-arabinofuranose unit, may contain side chains of arabinose, xylose, galactose and glucuronic acid.
According to this variant, the polysaccharide is preferably hyaluronic acid or a salt thereof.
The at least one hydrophilic gelling agent may be present in an amount of, for example, 0.001 wt% to 10 wt%, preferably 0.01 wt% to 5 wt%, more preferably 0.05 wt% to 3 wt%, relative to the total weight of the second composition.
Active agent
According to one embodiment of the invention, the first composition may comprise at least one active agent.
According to one embodiment of the invention, the second composition may comprise at least one active agent.
When the first composition comprises the at least one active agent, it may be incorporated into the first composition, in particular by means of an alternating electric field. The one or more active agents may be incorporated, in particular, in the powder state.
Among all the active agents which can be used in the present invention, mention may be made in particular of: alpha-or beta-hydroxy acids, such as lactic acid, glycolic acid, citric acid, 5-octanoylsalicylic acid, alpha-hydroxydecanoic acid, alpha-hydroxy lauric acid, tartaric acid, glucuronic acid, galacturonic acid, acrylic acid, alpha-hydroxybutyric acid, alpha-hydroxyisobutyric acid, malic acid, mandelic acid, phosphoric acid, pyruvic acid, lactobionic acid and salicylic acid.
Anti-acne agents such as salicylic acid or benzoyl peroxide, octopirox, dextro-and levo-sulfur-containing amino acids, their salts and their N-acetyl derivatives such as N-acetylcysteine, or agents which attempt to prevent skin aging and/or improve its condition, such as the alpha-and beta-hydroxy acids mentioned above, retinoids such as retinoic acid, retinol and its esters, e.g. retinol propionate and retinol acetate, or retinol palmitate, nicotinamide, allantoin, aloe vera extract, azelaic acid, bisabolol, phytic acid, collagen, or agents which stimulate collagen formation, vitamins such as vitamin C or derivatives thereof, such as ascorbyl glucoside, vitamin E or derivatives thereof, vitamin a or derivatives thereof, vitamin F or derivatives thereof, dextro-and levo-sulfur-containing amino acids and derivatives thereof as mentioned above, elastin, N-acetyl D-glucosamine, luteolin or antioxidants, such as green tea or active fractions thereof, glycerol, laponite, caffeine, aromatic essential oils (essential aromatic oils), colorants, radical scavengers, humectants, depigmenting agents (depigmenting agents), agents for improving skin color, such as artificial tanning agents of the dihydroxyacetone or tyrosine ester type, sebum regulators (lipo-regulators), softeners, anti-wrinkle agents, keratolytic agents, refreshing agents (freshenes), deodorants, anesthetics, nutritional agents and mixtures thereof. Bleaching agents (bleaching agents) such as kojic acid, ascorbyl phosphate, ascorbyl glucoside, ascorbic acid and mixtures thereof may also be used.
In the case of facial masks, active agents for improving skin conditions, such as moisturizers or agents that help improve the natural lipid barrier, such as ceramides, cholesterol sulfates and/or fatty acids and mixtures thereof, may also be used. Enzymes active on the skin, such as proteases, lipases, cerebrosidase and/or melanases and mixtures thereof may also be used.
As other examples of active agents that may be suitable for use in the practice of the present invention, there are pharmaceutical agents (agents for drugs), peptides, proteins, detectable labels (detectable labels), contrast agents, analgesics, anesthetics, antibacterial agents, antiyeast agents, antifungal agents, antiviral agents, anti-dermatitis agents, antipruritics, antiemetics, vascular protectants, antihalation agents, anti-irritants, anti-inflammatory agents, immunomodulators, anti-hyperkeratosis agents (anti-hyperkeratolytic agents), dry skin treatments, antiperspirants, antipsoriatic agents, anti-dandruff agents, anti-aging agents, anti-asthma agents and bronchodilators, sunscreens, antihistamines, healing agents, corticosteroids, tanning agents, and mixtures thereof.
The amount of the at least one active agent in the first composition and/or the second composition may be adjusted according to the intended use of the kit.
Alkali metal hyaluronate compound
Hyaluronic acid compounds may also be used as active agents according to the invention. The hyaluronic acid compound is preferably an alkali metal hyaluronic acid compound.
The term "alkali metal hyaluronate compound" refers in particular to an alkali metal salt of hyaluronic acid (hyaluronate) or a derivative thereof. The alkali metal hyaluronate compound is water soluble.
In the context of the present invention, the term "hyaluronic acid or derivative thereof" specifically covers the basic units of hyaluronic acid of the formula:
。
it is the smallest fraction (fraction) of hyaluronic acid comprising disaccharide dimers, D-glucuronic acid and N-acetamido glucose.
The term "hyaluronic acid or derivative thereof" also comprises in the context of the present invention linear polymers comprising the above-mentioned polymeric units linked together in the chain via alternating β (1, 4) and β (1, 3) glycosidic linkages, the molecular weight (Mw) of which may be between 380 and 13 000 000 daltons. Such molecular weight depends to a large extent on the source of the hyaluronic acid obtained and/or the method of preparation.
In the natural state, hyaluronic acid is present in pericellular gels (pericellular gels), in the matrix of connective tissue of vertebrate organs, such as dermis and epithelial tissue, and in particular in the epidermis, in synovial fluid of joints, in vitreous humor, in human umbilical cord and in cockscomb (crista galli apophysis).
Thus, the term "hyaluronic acid or derivative thereof" comprises all fractions or subunits (sub-units) of hyaluronic acid having a molecular weight in particular within the molecular weight ranges highlighted above.
As an illustration of the various hyaluronic acid fractions, reference may be made to the "Hyaluronan fragments: an information-rich system", R.Stern et al European Journal of Cell Biology (2006) 699-715, which reviews the listed biological activities of hyaluronic acid according to molecular weight.
According to a preferred embodiment of the invention, the hyaluronic acid fraction suitable for the uses covered by the invention has a molecular weight of between 50 and 5 000 Da, in particular between 100 000 and 5 000 Da, especially between 400 000 and 5 000 Da. In this case, the term used is high molecular weight hyaluronic acid.
Alternatively, the hyaluronic acid fraction, which is also suitable for the uses covered by the invention, has a molecular weight between 50 000 and 400 000 Da. In this case, the term used is medium molecular weight hyaluronic acid.
Still alternatively, the hyaluronic acid fraction applicable for the uses covered by the invention has a molecular weight of less than 50 000 Da. In this case, the term used is low molecular weight hyaluronic acid.
Finally, the term "hyaluronic acid or derivative thereof" also comprises hyaluronic acid esters, in particular those in which all or part of the carboxylic groups of the acid function are esterified with an oxyethylenated alkyl group or alcohol containing from 1 to 20 carbon atoms, in particular having a degree of substitution at the D-glucuronic acid level of hyaluronic acid of from 0.5 to 50%.
More specifically, hyaluronic acid or hyaluronate may be reacted with an alkylene oxide, such as ethylene oxide or propylene oxide, to form a polyglycol hyaluronate (polyglycol hyaluronates). The polyglycol segment is bonded to the hyaluronic acid via a carboxyl group. Typically, hyaluronic acid or hyaluronate is reacted with propylene oxide to form polypropylene glycol hyaluronate, and ethylene oxide to form polyethylene glycol hyaluronate.
Mention may also be made of the methyl, ethyl, n-propyl, n-pentyl, benzyl and dodecyl esters of hyaluronic acid. These esters are described in particular in D. Campoccia et al, "Semisynthetic resorbable materials from hyaluronan esterification", biomaterials 19 (1998) 2101-2127.
The molecular weights indicated above also apply to the hyaluronate.
Auxiliary agent
In a known manner, the second composition according to the invention may also contain adjuvants usual in cosmetics and/or dermatology, such as preservatives, antioxidants, pH regulators (acidic or basic), fragrances, fillers, bactericides, odor absorbers, colorants (pigments and dyes), emulsifiers and lipid vesicles.
Needless to say, the person skilled in the art will take care to choose this or these optional further compounds and/or their amounts such that the addition considered does not or substantially does not adversely affect the benefit of the second composition according to the invention.
Galenic form (Galenic form)
The second composition according to the invention may be in various forms, in particular in the form of an aqueous solution, dispersion or emulsion, such as in particular a water/oil or oil/water emulsion or multiple emulsion.
The emulsion may have an oily or aqueous continuous phase. Such emulsions may be, for example, reverse phase (W/O) emulsions or direct (O/W) emulsions, or multiple emulsions (W/O/W or O/W/O).
In the case of emulsions, direct (O/W) emulsions are preferred.
In particular, the second composition according to the invention may be in the form of an oil-in-water (O/W) emulsion, a water-in-oil (W/O) emulsion or a multiple emulsion, preferably an oil-in-water (O/W) emulsion.
The second composition of the present invention is preferably an aqueous solution.
According to a preferred embodiment of the invention, the kit is presented as a mask comprising:
1) A nonwoven fabric (or towel) made of hydroxyl-rich fibers comprising 0.01 to 5 wt%, preferably 0.02 to 1 wt%, or preferably 0.04 to 0.5 wt%, and 0.001 to 1 wt%, especially 0.01 to 0.1 wt%, such as 0.01 to 0.06 wt%, HEC or HPC, relative to the total weight of the nonwoven fabric, and
2) A composition comprising, relative to the total weight of the composition, from 10% to 99% by weight, preferably from 50% to 99% by weight, of at least one aqueous phase, from 0.1% to 0.5% by weight, preferably from 0.1% to 0.3% by weight of sodium alginate and from 0.1% to 0.5% by weight, preferably from 0.2% to 0.4% by weight of sodium citrate,
wherein the weight ratio of the nonwoven fabric to the composition is from 1:3 to 1:20, preferably from 1:8 to 1:15.
Different embodiments of the kit
Based on a discussion of a kit according to the present invention comprising a first composition and a second composition, it is to be understood that the following embodiments are also within the spirit of the present invention.
Specifically, according to the present invention, there is provided a mask pack 1 comprising:
1) A first composition comprising at least one water-insoluble multivalent metal salt and at least one water-soluble polyhydroxy polymer, and
2) A fourth composition that is free of water comprising:
a) At least one water-soluble multivalent metal ion chelating agent, and
b) At least one water-soluble gelling agent capable of forming a gel with the polyvalent metal ion,
wherein the first composition and the fourth composition are placed apart from each other.
For such a mask pack 1, the first composition and its components, including the water insoluble salt and the water soluble polyhydroxy polymer, and the fourth composition, including the water soluble chelating agent, the water soluble gelling agent, etc., may be substantially identical to the kit of the present invention, wherein the fourth composition substantially corresponds to the second composition except that no water is present. The mask pack 1 may also be constructed substantially the same as the kit of the present invention. In addition, the amounts of the composition of the mask pack 1, the components of the composition and the ratio therebetween may be referred to the kit of the present invention.
To apply the mask pack 1, the fourth composition may be mixed with water to form an aqueous solution of the fourth composition. Obviously, such an aqueous solution substantially corresponds to the second composition of the kit according to the invention. The aqueous solution is then mixed with the first composition, for example with reference to the way in which the first composition and the second composition of the kit according to the invention are mixed.
In particular, the mask pack 1 according to the present invention comprises:
1) A nonwoven fabric (or towel) comprising 0.01 to 5 wt%, preferably 0.02 to 1 wt%, or preferably 0.04 to 0.5 wt% of calcium sulphate or calcium carbonate and 0.001 to 1 wt%, especially 0.01 to 0.1 wt%, such as 0.01 to 0.06 wt% of HEC or HPC, relative to the total weight of the nonwoven fabric, and
2) A fourth composition which is free of water and comprises, relative to the total weight of the composition, from 0.1% to 0.5% by weight, preferably from 0.1% to 0.3% by weight, of a water-soluble chelating agent and from 0.1% to 0.5% by weight, preferably from 0.2% to 0.4% by weight, of a water-soluble gelling agent,
wherein the weight ratio of nonwoven to the fourth composition is from 1:3 to 1:20, preferably from 1:8 to 1:15.
Method and use
The first composition and the second/fourth composition according to the present invention may be generally prepared according to common general knowledge of a person skilled in the art. However, it is to be understood that the skilled person may choose a preparation method based on his general knowledge, taking into account the nature of the ingredients used, e.g. their solubility in the vehicle and the envisaged use for the composition or kit.
According to one embodiment, the kit according to the invention can be used for caring for keratin materials, in particular the face. Such use may be represented by a method of caring for keratin materials, in particular the face, comprising the step of compounding the first and second compositions of the kit in a predetermined weight ratio, and then applying the mixture thus obtained as a mask to the keratin materials.
According to one embodiment, the kit according to the invention may be used for managing skin wounds, for preventing post-operative adhesion formation or for filling or repairing osteochondral defects, etc. Such use may be manifested as a method of managing skin wounds, preventing post-operative adhesion formation or filling or repairing osteochondral defects, comprising the steps of compounding the first and second compositions of the kit in a predetermined weight ratio, and then applying as a coating (mask) or a pad (stuffer) to the site where the mixture thus obtained is desired.
Notwithstanding that the numerical ranges and parameters setting forth the broad scope of the invention are approximations, the numerical values set forth in the specific examples are reported as precisely as possible. Any numerical value, however, inherently contains certain errors necessarily resulting from the standard deviation found in their respective testing measurements. The following examples are intended to illustrate the invention and are not thereby limiting its scope.
Examples
The amounts/concentrations of ingredients in the following compositions/formulations are expressed in weight percent relative to the total weight of each composition/formulation.
Example 1
I. Preparation
As a second composition, inventive formulations a and B and comparative formulation a were prepared.
TABLE 1
In table 1, comparative a does not contain trisodium citrate as compared to formulation a of the present invention.
Procedure for preparing the second composition using the formulation in table 1: all ingredients were placed in a beaker, heated to 60 ℃ and homogenized until uniform, cooled to room temperature.
The preparation procedure of the mask comprises the following steps: each of 0.75 g of formulations A to B and comparative A was put together with a nonwoven fabric of weight 1.3 g made of 20% by weight calcium alginate fibers and 80% by weight lyocell fibers, sold by Sanjiang under the name M762R-40CN, respectively.
II. Evaluation of the mask and comparative mask of the invention
The mask of the present invention and the comparative mask were evaluated using the following procedure.
Texture transition evaluation method
Five panelists visually rated the gel area on the towel and rated from poor to excellent, with the average based on the rating being divided into the following four categories: "excellent" (> 50%), "good" (30-50%), "general" (10-30%) or "poor" (< 10%).
Freshness evaluation method
Five panelists evaluated the skin for greasiness by tactile means as the face gently moved the finger abdomen.
The evaluation method is that the mask is applied to the face for 15 minutes, and then the skin is removed and massaged. The greasy feel of the skin is perceived by moving the abdomen of the finger over the face. Each panel then gave a score of 0 to 15. The lower the greasy feel, the higher the score given.
Evaluation index: we classified from poor to excellent classification into the following four classes based on scores: "excellent" (> 12), "good" (8-12), "general" (4-8), "bad" (0-4).
Skin adhesion evaluation method
Five panelists visually evaluated the degree of facial mask adhesion to the face with a mirror under standardized illumination, and the amount of air bubbles around the eyes, nose and mouth.
The evaluation method is to apply a mask to the face and observe the amount of bubbles around the eyes, nose and mouth. Each panel then gave a score of 0 to 15. The fewer bubbles, the higher the score given.
Evaluation index: we classified from poor to excellent classification into the following four classes based on scores: "excellent" (> 12), "good" (8-12), "general" (4-8), "bad" (0-4).
Hydration effect evaluation method
Five panelists evaluated the hydration of the mask based on the fullness (plumpy), fine line improvement, and soft skin provided by the formulation.
The evaluation method is that the mask is applied to the face for 15 minutes, and then the skin is removed and massaged. The extent of wrinkles on the forehead and nasolabial folds was observed, the cheeks were touched with the index and middle fingers and the skin softness was perceived by tactile means, and the extent of fine lines on the cheeks was observed. Each panel gave a score of 0 to 15. The more skin is full, the higher the score is given.
Evaluation index: we classified from poor to excellent classification into the following four classes based on scores: "excellent" (> 12), "good" (8-12), "general" (4-8), "bad" (0-4).
Method for evaluating moisture delivery ability
Five panelists visually evaluated the amount of juice left on the skin after removal of the mask with a mirror under standardized illumination.
The evaluation method is that the mask is applied to the face for 15 minutes and then removed. The amount of juice left on the skin was visually observed. Each panel then gave a score of 0 to 15. The more juice that remains on the skin, the higher the score given.
Evaluation index: we classified from poor to excellent classification into the following four classes based on scores: "excellent" (> 12), "good" (8-12), "general" (4-8), "bad" (0-4).
The results obtained are detailed in the following table:
TABLE 2
Formulation A | Formulation B | Comparative formulation A | |
Texture transition | Good quality | Excellent in | Difference of difference |
Skin adhesion | Excellent in | Excellent in | In general |
Fresh feeling | Excellent in | In general | Good quality |
Hydration effect | Good quality | Excellent in | In general |
Moisture delivery capability | Excellent in | In general | Difference of difference |
Conclusion (III)
The mask of the present invention is superior to the comparative mask in beneficial properties such as texture transition, hydration effect and moisture delivery ability.
Example 2:
as a first composition, inventive formulation C and comparative formulations B-D were prepared.
TABLE 3 Table 3
The preparation procedure of the mask comprises the following steps: 0.75 grams of formulation A was placed with a 1.3 gram nonwoven made from formulation C and comparative formulations B-D, respectively, to provide mask C and comparative masks B-D, respectively.
II. Evaluation of the mask and comparative mask of the invention
The mask of the present invention and the comparative mask were evaluated using the following procedure.
Softness evaluation method
(1) Five panelists manually rated the gel area on the towel by touch and rated from poor to excellent, with the average based on the rating being classified into the following 3 categories: "excellent" (uniform softening), "general" (softening but non-uniform) or "poor" (non-softening).
TABLE 4 Table 4
Mask C | Contrast mask B | Contrast mask C | Contrast mask D | |
Evaluation | Excellent in | In general | In general | Difference of difference |
(2) The softening effect is evaluated indirectly by measuring the deformation of the mask, as the softened mask will result in deformation.
Deformation (%) = ((value measured after fresh mixing) - (initial value))/(initial value).
TABLE 5
Mask C | Contrast mask B | |
Deformation of | 13.80% | 8.42% |
Conclusion (III)
The mask of the invention is superior to the comparative mask in softness.
The foregoing description illustrates and describes the present disclosure. In addition, the disclosure shows and describes only the preferred embodiments of the disclosure, but as mentioned above, it is to be understood that variations or modifications can be made within the scope of the concepts as expressed herein commensurate with the above teachings and/or the skill or knowledge of the relevant art. The above description is further intended to explain the best modes known for practicing the disclosure and to enable others skilled in the art to utilize the disclosure in such, or other, embodiments and with the various modifications required by the particular applications or uses disclosed herein. Accordingly, this description is not intended to limit the disclosure to the form disclosed herein. It is also intended that the appended claims be construed to include alternative embodiments.
All publications, patents, and patent applications cited in this specification are herein incorporated by reference for any and all purposes as if each individual publication, patent, or patent application were specifically and individually indicated to be incorporated by reference. In the event of inconsistencies, the present disclosure controls.
Claims (31)
1. A kit, comprising:
1) A first composition comprising at least one water insoluble multivalent metal salt and at least one water soluble polyhydroxy polymer, wherein the water insoluble multivalent metal salt is selected from water insoluble salts of calcium, strontium, zinc, copper, manganese, or mixtures thereof, and wherein the water soluble polyhydroxy polymer comprises polyhydroxy cellulose, and
2) A second composition comprising at least one aqueous phase, and
a) At least one water-soluble multivalent metal ion chelator, wherein the at least one water-soluble multivalent metal ion chelator is selected from the group consisting of sodium citrate, disodium EDTA, tetrasodium GLDA, trisodium EDDS, sodium phytate, potassium phytate, and mixtures thereof, and
b) At least one water-soluble gelling agent capable of forming a gel with multivalent metal ions, wherein the water-soluble gelling agent is selected from the group consisting of alkali metal alginic acid compounds;
wherein the weight ratio of the first composition to the second composition is from 1:3 to 1:20,
wherein the first composition and the second composition are placed apart from each other.
2. The kit according to claim 1, wherein the gelling agent is specifically selected to have a lower capacity to bind multivalent metal ions than the chelating agent.
3. Kit according to claim 1 or 2, wherein the at least one water-insoluble multivalent metal salt is a water-insoluble calcium salt selected from calcium alginate, calcium sulfate and calcium carbonate or mixtures thereof.
4. The kit according to claim 1 or 2, wherein the first composition comprises the at least one water-soluble polyhydroxy polymer in a content of from 0.001% to 1% by weight, relative to the total weight of the first composition.
5. The kit according to claim 1 or 2, wherein the first composition further comprises additional hydroxyl-enriched fibers, wherein the at least one water-insoluble multivalent metal salt and the at least one water-soluble polyhydroxy polymer are loaded onto the additional fibers.
6. The kit of claim 5, wherein the water-insoluble multivalent metal salt is in the form of fibers that are formed with additional fibers into a water-insoluble substrate onto which the water-soluble polyhydroxy polymer is loaded.
7. The kit of claim 6, wherein the water-insoluble substrate comprises water-insoluble multivalent metal salt fibers in an amount of 10 to 80 wt% relative to the total weight of the water-insoluble substrate, and comprises the additional fibers in an amount of 10 to 80 wt%.
8. The kit of claim 5, wherein the additional fibers are formed into a water insoluble substrate onto which both the water insoluble multivalent metal salt and the water soluble polyhydroxy polymer are loaded.
9. The kit of claim 8, wherein the water-insoluble substrate comprises water-insoluble multivalent metal salt fibers in an amount of 0.01 wt% to 5 wt% relative to the total weight of the water-insoluble substrate.
10. The kit according to claim 1 or 2, wherein the multivalent metal ion chelating agent comprises an aminocarboxylic acid, a hydroxycarboxylic acid, a hydroxyaminocarboxylic acid, a polyphosphonic acid, other phosphorus-containing organic acids or mixtures thereof.
11. The kit according to claim 1 or 2, wherein the at least one water-soluble multivalent metal ion chelating agent is present in the second composition at 0.1 to 1 wt% relative to the total weight of the second composition.
12. The kit according to claim 1, wherein the alkali metal alginic compound is selected from alkali metal alginates, alkali metal salts of alginic acid derivatives or mixtures thereof.
13. The kit according to claim 12, wherein the alkali metal alginic compound is selected from sodium alginate and potassium alginate.
14. Kit according to claim 1 or 2, wherein the at least one water-soluble gelling agent is present in the second composition in a range of 0.1 to 0.5% by weight relative to the total weight of the second composition.
15. Kit according to claim 1 or 2, wherein the at least one aqueous phase is present in the second composition in a range of from 10% to 99% by weight relative to the total weight of the second composition.
16. Kit according to claim 1 or 2, wherein the second composition comprises at least one hydrophilic gelling agent and/or at least one active agent.
17. The kit according to claim 1 or 2, wherein the second composition comprises the water-soluble polyhydroxy polymer.
18. Kit according to claim 1 or 2, in the form of a mask comprising:
1) A nonwoven fabric made from hydroxyl-rich fibers comprising 0.01 to 5 wt% of calcium sulfate or calcium carbonate, and 0.001 to 1 wt% of HEC or HPC, relative to the total weight of the nonwoven fabric, and
2) A composition comprising, relative to the total weight of the composition, from 10% to 99% by weight of at least one aqueous phase, from 0.1% to 0.5% by weight of a water-soluble chelating agent and from 0.1% to 0.5% by weight of a water-soluble gelling agent,
Wherein the weight ratio of the nonwoven fabric to the composition is from 1:3 to 1:20.
19. Kit according to claim 1 or 2, wherein the amounts of the chelating agent and the gelling agent are selected such that the molar ratio of the part to be released from the chelating agent that is chelated with multivalent cations to the part to be released from the gelling agent that is gellable with multivalent cations is from 10:1 to 1:1.
20. The kit of claim 1, wherein the water-soluble polyhydroxy polymer comprises hydroxyethyl cellulose, hydroxypropyl methylcellulose, hydroxyethyl ethylcellulose, or hydroxybutyl methylcellulose.
21. The kit of claim 5, wherein the first composition further comprises regenerated cellulose or cotton fibers.
22. The kit of claim 12, wherein the alkali metal alginic compound is selected from the group consisting of sodium alginate, potassium alginate, lithium alginate, sodium alginate polyglycolate, potassium alginate polyglycolate, lithium alginate polyglycolate, or mixtures thereof.
23. The kit of claim 1, wherein the weight ratio of the first composition to the second composition is from 1:8 to 1:15.
24. The kit of claim 19, wherein the amounts of the chelating agent and the gelling agent are selected such that the molar ratio of the portion to be released from the chelating agent that is chelated with multivalent cations to the portion to be released from the gelling agent that is gellable with multivalent cations is from 5:1 to 2:1.
25. Non-therapeutic use of the kit according to any one of the preceding claims for caring for keratin materials.
26. A non-therapeutic method for caring for keratin materials, comprising the step of compounding the first and second compositions of the kit according to any one of the preceding claims 1 to 24 in a weight ratio of the first composition to the second composition ranging from 1:3 to 1:20, and then applying to the location where the mixture thus obtained is desired.
27. Use of a second composition as claimed in any one of the preceding claims 1-24 as a juice or part of a juice of a mask product, wherein the mask product comprises, separate from the second composition, a fabric or towel comprising the at least one water-insoluble multivalent metal salt.
28. A mask pack 1 comprising:
1) A first composition comprising at least one water insoluble multivalent metal salt, at least one hydroxyl-rich fiber, and at least one water soluble polyhydroxy polymer, wherein the at least one water soluble polyhydroxy polymer is homogeneously loaded onto the hydroxyl-rich fiber, wherein the water insoluble multivalent metal salt is selected from water insoluble salts of calcium, strontium, zinc, copper, manganese, or mixtures thereof, and wherein the water soluble polyhydroxy polymer comprises polyhydroxy cellulose, and
2) A fourth composition comprising at least one aqueous phase, and
b) At least one water-soluble gelling agent capable of forming a gel with multivalent metal ions, wherein the at least one water-soluble gelling agent comprises an alkali metal salt of alginic acid,
wherein the first composition and the fourth composition are placed apart from each other.
29. The mask pack 1 of claim 28, wherein the water-insoluble multivalent metal salt is calcium alginate, calcium sulfate, or calcium carbonate.
30. The mask pack 1 of claim 28 or 29, wherein the at least one hydroxyl-rich fiber is selected from the group consisting of viscose, modal, lyocell, cuprammonium, cotton, and mixtures thereof.
31. The mask pack 1 of claim 28 or 29, wherein the water-soluble polyhydroxy polymer is hydroxyethyl cellulose or hydroxypropyl cellulose or a mixture thereof, and the at least one hydroxyl-rich fiber is selected from the group consisting of viscose, modal, lyocell, cuprammonium, cotton, and mixtures thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210758396.0A CN115192473B (en) | 2018-12-29 | 2018-12-29 | Kit for caring skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2018/125363 WO2020133361A1 (en) | 2018-12-29 | 2018-12-29 | Kit for caring for the skin |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210758396.0A Division CN115192473B (en) | 2018-12-29 | 2018-12-29 | Kit for caring skin |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113194908A CN113194908A (en) | 2021-07-30 |
CN113194908B true CN113194908B (en) | 2024-01-16 |
Family
ID=71129544
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210758396.0A Active CN115192473B (en) | 2018-12-29 | 2018-12-29 | Kit for caring skin |
CN201880100560.0A Active CN113194908B (en) | 2018-12-29 | 2018-12-29 | Kit for caring skin |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210758396.0A Active CN115192473B (en) | 2018-12-29 | 2018-12-29 | Kit for caring skin |
Country Status (2)
Country | Link |
---|---|
CN (2) | CN115192473B (en) |
WO (1) | WO2020133361A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022205059A1 (en) * | 2021-03-31 | 2022-10-06 | L'oreal | Compositions for caring for skin and a package for containing the same |
WO2022226872A1 (en) * | 2021-04-29 | 2022-11-03 | L'oreal | Kit for caring for the skin |
EP4391988A1 (en) * | 2021-08-25 | 2024-07-03 | L'oreal | Mask for caring for keratin materials |
WO2023184295A1 (en) * | 2022-03-31 | 2023-10-05 | L'oreal | Composition for caring for keratin material |
EP4507663A1 (en) * | 2022-03-31 | 2025-02-19 | L'oreal | Kit for caring for keratin materials |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010070234A2 (en) * | 2008-12-19 | 2010-06-24 | L'oreal | Kit for coating keratin substances comprising a polysaccharide and an ionic or dative complexing agent |
CN102940583A (en) * | 2012-11-26 | 2013-02-27 | 中国工程物理研究院核物理与化学研究所 | Thermosensitive hydrogel capable of being used as nutrition mask and preparation method of thermosensitive hydrogel |
JP2016222612A (en) * | 2015-06-01 | 2016-12-28 | 昭和電工株式会社 | Cosmetic and skin external preparation |
JP2017052706A (en) * | 2015-09-07 | 2017-03-16 | 一丸ファルコス株式会社 | Cosmetic composition containing granules |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8349301B2 (en) * | 2002-06-04 | 2013-01-08 | The Procter & Gamble Company | Shampoo containing a gel network |
US20060104931A1 (en) * | 2004-11-12 | 2006-05-18 | Takeshi Fukutome | Cosmetic treatment article comprising substrate and gel composition |
FR3002448B1 (en) * | 2013-02-25 | 2015-04-03 | Oreal | COSMETIC COMPOSITION OF GEL TYPE |
FR3025100B1 (en) * | 2014-08-28 | 2016-12-09 | Oreal | GEL-TYPE COSMETIC COMPOSITION IMPROVED |
FR3030231B1 (en) * | 2014-12-23 | 2018-08-24 | L'oreal | USE OF A FATTY ACID ESTER FOR MATIFYING THE SKIN AND COMPOSITION COMPRISING SAID ESTER |
TR201619953A2 (en) * | 2016-12-28 | 2018-07-23 | Buelent Karaagac | TOPICAL THERAPEUTIC FORMULATIONS |
-
2018
- 2018-12-29 CN CN202210758396.0A patent/CN115192473B/en active Active
- 2018-12-29 CN CN201880100560.0A patent/CN113194908B/en active Active
- 2018-12-29 WO PCT/CN2018/125363 patent/WO2020133361A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010070234A2 (en) * | 2008-12-19 | 2010-06-24 | L'oreal | Kit for coating keratin substances comprising a polysaccharide and an ionic or dative complexing agent |
CN102940583A (en) * | 2012-11-26 | 2013-02-27 | 中国工程物理研究院核物理与化学研究所 | Thermosensitive hydrogel capable of being used as nutrition mask and preparation method of thermosensitive hydrogel |
JP2016222612A (en) * | 2015-06-01 | 2016-12-28 | 昭和電工株式会社 | Cosmetic and skin external preparation |
JP2017052706A (en) * | 2015-09-07 | 2017-03-16 | 一丸ファルコス株式会社 | Cosmetic composition containing granules |
Also Published As
Publication number | Publication date |
---|---|
CN113194908A (en) | 2021-07-30 |
CN115192473A (en) | 2022-10-18 |
WO2020133361A1 (en) | 2020-07-02 |
CN115192473B (en) | 2024-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113194908B (en) | Kit for caring skin | |
CN112334124A (en) | Kit for caring for skin | |
WO2019047954A1 (en) | Kit for caring for the skin | |
US11304881B2 (en) | Composition based on an aqueous phase containing a dispersion of an anhydrous composite material | |
CN113194906B (en) | Kit for skin care | |
EP2088994B1 (en) | Dispersible glyoxal crosslinked cationic guar | |
CN113226248A (en) | Set for caring skin | |
KR20150124978A (en) | Gel-type cosmetic composition | |
CN113194921A (en) | Set for caring skin | |
CN113498336A (en) | Kit for skin care | |
CN114340591A (en) | Skin care kit | |
WO2019185915A1 (en) | Foaming aqueous gel comprising a modified starch and a non-starchy polysaccharide | |
CN110799246B (en) | Hair restoration composition | |
Gruber | Polysaccharide-based polymers | |
EP2945599B1 (en) | Cosmetic composition comprising a specific polysaccharide, an anionic fixing polymer and a liquid monoalcohol or polyol, and cosmetic treatment method employing it | |
JP7118634B2 (en) | A composition in the form of an O/W emulsion comprising a cereal fermentation product and hectorite | |
CN115666492A (en) | Skin care kit | |
CN118973554A (en) | Composition for caring for keratin materials | |
CN115768397B (en) | Gelling composition comprising short chain fatty acid salts | |
WO2022123016A1 (en) | Cosmetic substrate of natural origin | |
JP2024085649A (en) | Composition comprising combination of electrolyte and polysaccharide | |
WO2021245081A1 (en) | Composition comprising at least three types of polysaccharides, at least one pasty compound of plant origin and water | |
WO2019185913A1 (en) | Anhydrous exfoliating composition comprising c3-c10 polyols and polysaccharides | |
WO2024128168A1 (en) | Composition comprising electrolyte and combination of polysaccharides | |
FR3023476A1 (en) | AQUEOUS SOLID COMPOSITION CONTAINING A FATTY ACID SALT, A POLYOL AND A HYDROPHILIC GELIFIER |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Xu Lingwei Inventor after: Jade Flower Inventor after: Yu Kun Inventor after: Yan Zhipeng Inventor before: Xu Lingwei Inventor before: Ye Yuhua |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |